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cord injury” 
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AIM 
 
To test the hypothesis that the initiation of intermittent clean 
catheterization (ICC) under antibiotic cover is not superior to the 
initiation of ICC without antibiotic cover in long term catheterized 
spinal cord injury patients. 
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INTRODUCTION 
Neurogenic bladder dysfunction is a great challenge in patients with traumatic 
or non-traumatic spinal cord injuries (SCI). The neurological level of injury and 
the completeness of the spinal cord lesion are the two main factors deciding the 
type of bladder dysfunction, with the bladder evacuation function varying 
between detrusor over-activity and no detrusor activity.(1,2) Bladder 
dysfunction continues to affect the quality of life of individuals with SCI many 
years following the initial trauma.(3)  
 
Neurogenic bladder can result in multiple complications including urinary tract 
infections, calculi, hydronephrosis and renal failure.Prior to the 1970s, renal 
disease was the leading cause of mortality in chronic SCI. In the mid-1970s, 
Lapides et al. reported on the effectiveness of intermittent clean catheterisation 
(ICC)  in those with SCI to improve continence and allow storage at low 
pressures.(4)Since the advent of these programs, the prevalence of renal disease 
has decreased dramatically. The survival rates in spinal cord injury patients 
have improved over the last few decades and a better enhanced urinary tract 
management has doubtlessly played a major role in this process. (5, 6)  
  
Catheter-related urinary tract infections (CAUTI) is a frequent complication in 
patients on indwelling urethral catheter or intermittent catheterisation, and 
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occurs because urethral catheters inoculate organisms into the bladder and 
promote colonisation by providing a surface for bacterial adhesion and causing 
mucosal irritation. The presence of a urinary catheter is the most important risk 
for bacteraemia. 
Once the catheter is placed, the risk of acquiring bacteriuria has been estimated 
as 5% for each day of catheterisation, accumulating to 100% in four weeks. The 
longer the catheter remains in situ, the higher the risk of infection. Among long-
term catheterized patients  i.e. patients on indwelling urethral catheter for more 
than 14 days, infections are mostly polymicrobial in up to 95% of urine 
specimens. Such specimens commonly have 3-4 bacterial species, each at 
concentrations of 10
5 
CFU/ml or more.(7) 
 
Several  studies have investigated the role of  antibiotic prophylaxis in patients 
on long term indwelling catheterisation and those on ICC(8,9) to prevent UTI 
and the potential for bacteraemia and septicaemia. 
.
 This is especially relevant 
in the light of the reported overuse of, and increased resistance to antibiotics. 
Possible benefits of antimicrobial prophylaxis must be balanced against 
possible adverse effects. Such a risk-benefit analysis cannot be reliably 
estimated from the currently available trials.  Precise guidelines for the use of 
antibiotics have yet to be established and studies have shown great variation in 
practice amongst healthcare professionals
. 
(10)
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Two Cochrane reviews assessed the role of antibiotic prophylaxis in subjects 
with short-term and long term catheters. (7, 11) Both reviews found inadequate 
data for the use of prophylactic antibiotics and recommended that further 
studies and randomised controlled trials are essential in this aspect. Even 
though an asymptomatic bacteraemia rate of around 10% per catheter change 
has been stated in bacteriuric patients with long-term catheters, studies have 
concluded that it is imprudent to advocate the use of prophylactic antibiotics for 
long-term catheterised patients.(12,13)
  
 
However, there are no systematic studies regarding the role of prophylactic 
antibiotics during the initiation of ICC in these patients, in spite of the fact that 
during this procedure, there is chance of urinary stasis and in turn more chance 
for UTI. The current study is a clinical trial on the role of Antibiotics during 
change over from continuous bladder drainage to intermittent clean 
catheterization in patients with spinal cord injury.  
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JUSTIFICATION FOR THE STUDY 
There are many studies related to antibiotic prophylaxis in patients with spinal 
cord injury on long term indwelling urethral catheterisation and those on ICC. 
But there are no specific studies regarding the role of antibiotics during the 
initiation of ICC in long term catheterised patients with spinal cord injury. 
 
 During the initiation of ICC on a long term catheterised patient, there is 
increased chance of retention of urine in the bladder. Urinary retention in turn 
causing bladder distension is considered as risk factor for UTI(14,15). 
Moreover the periurethral area of the subjects using ICC is colonized with 
enteric organisms supposed to have derived from the gastrointestinal tract. ICC 
facilitates the inoculation of periurethral bacteria into the bladder and hence 
bacteriuria is very common (14,16). Also the patient who is new to the 
procedure has chances of lack of proper clean technique during the ICC. Hence 
there is a likely chance for increased symptomatic UTI during the first week of 
initiation of ICC. 
 
The protocol being followed in the Department of Physical Medicine & 
Rehabilitation, CMC Vellore has involved treatment with urine culture specific 
1
st
/2
nd 
 line antibiotics(oral/parenteral) while initiating ICC in long term 
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catheterised patients with spinal cord injury. The expense of this treatment may 
range from  200-1500. 
 
 The current study is a pilot clinical trial on the role of Antibiotics during 
change over from continuous bladder drainage to intermittent clean 
catheterization in patients with spinal cord injury. If the study results prove no 
added benefits for antibiotics during the initiation of ICC, it may be 
economically beneficial for this group of patients.  
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Review of Literature 
 
 
Spinal cord injury: 
 
Spinal cord injury (SCI) is considered as “an ailment not to be treated”  in the 
Edwin Smith Surgical Papyrus, written between 2,500 and 3,000 BC(17).  The 
incidence of traumatic spinal cord injury in the United States is approximately 
40 new cases per million populations. This will be around 12,000 cases per 
year. Traumatic spinal cord injury primarily affects young adults in the age 
group between 16 and 30.  
 
Motor vehicle accidents account for 42% of cases, followed by falls (27.1%). 
Other causes include  acts of violence, primarily gunshot wounds  and 
recreational sporting activities.(18) Traumatic SCI, most commonly, causes 
cervical lesions approximately 50% followed by thoracic and then lumbosacral 
lesions. The C5 segment is the most common lesion level, followed by C4, C6, 
T12, C7, and L1. (19) Spinal cord injury can also be due to non-traumatic 
causes (20) as shown in Table 1. 
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Neurologic Level and Extent of Neurologic Deficit: 
According to the National SCI Database, tetraplegia (50.5%) is more common 
than paraplegia (44.1%). Considering neurologic categories, SCI patients are 
further divided into four groups namely,1) Incomplete tetraplegia (40.8 %), 2) 
Complete paraplegia(21.6%), 3)Incomplete paraplegia(21.4%) and 4) Complete 
tetraplegia (15.8%) (21). 
Table 1 Non-traumatic causes of spinal cord injury 
Neoplasm Primary  and metastatic tumours 
Infections  Pott’s spine, HIV myelopathy,   
Osteomyelitis of spine  
Inflammatory Transverse myelitis 
Vascular ArterioVenous malformation, spinal cord hypo-
perfusion, embolization or rarely thrombosis 
Degenerative Spondylosis  
Collagen vascular diseases Systemic  lupus erythematosus  
Sjögren syndrome 
Others 
Toxic -Metabolic Disorders             Nutritional  Deficiencies 
Radiation                                         Decompression Sickness  
Multiple Sclerosis                            Neuromyelitis  Optica  
Neurosarcoidosis                             Paraneoplastic Syndromes 
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Complications of Spinal cord injury: 
Injury to spinal cord can lead to several complications. Diseases of the 
respiratory system are the leading cause of death following SCI. They 
accounted for 37% of all deaths during the first year after SCI, and 21% of the 
deaths beyond the first year, in a large sample from the Model SCI Care 
Systems and Shriner’s Hospitals(22). Heart disease is positioned second, which 
is followed by septicaemia . The usual causes for septicaemia are urinary tract 
infections, infected pressure ulcers and respiratory infections.(4).  
 
Genitourinary (GU) disease (i.e., renal failure) was the leading cause of death 
30 years ago, which has declined noticeably today, most likely due to 
development in urological management. Urologic complications that can occur 
due to neurogenic bladder dysfunction include urinary tract infections, 
prostatitis, hydronephrosis, urinary tract calculi, urethral erosions, penoscrotal 
fistula, prostatitis, strictures, bladder cancer and renal failure. Among these 
urinary tract infections are the most common.  Before going into a detailed 
discussion of the neurogenic bladder and its complications, a description of the 
normal anatomy and physiology of the urinary system is essential (4). 
 
Complications usually seen in spinal cord injury patients are listed in the table 
2.  
 
11 
 
Table 2  Complications of SCI 
Complications  
Pulmonary  Pneumonia, atelectasis, respiratory failure, pleural 
complications  
Thromboembolic  DVT and pulmonary embolism (PE) 
CNS Nerve entrapment syndromes, post-traumatic 
syringomyelia or post-traumatic cystic 
myelopathy, tethering of cord and  late 
compression of cord, Neuropathic joints 
Musculoskeletal  Spasticity, contractures, osteoporosis and 
fractures, immobilization, hypercalcemia, calciuri 
and heterotopic ossification 
Gastrointestinal Adynamic  ileus , impaired evacuation of bowel, 
higher incidence of plaques , gingivitis, gastric 
erosions, gastric and duodenal ulcers, gall stones, 
pancreatitis 
Endocrine    Low testosterone in males 
Increased risk of  Diabetes Mellitus Type II 
Nocturnal diuresis due to altered diurnal rhythm 
of ADH secretion. 
 
Others 
 
Autonomic dysreflexia                    Disorders of Sexuality and fertility  
 
Pressure ulcers                                 Anemia 
   
Psychiatric complications 
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Urinary system -Anatomy and Physiology: 
 
Human urinary system can be broadly divided into upper urinary tract and 
lower urinary tract.  Upper urinary tract (UUT) consists of kidneys and ureters. 
Lower urinary tract (LUT) is comprised of the bladder, the internal urethral 
sphincter, the external urethral sphincter and the urethra.  
 
Upper urinary tract (UUT): 
 
The kidneys excrete the end products of metabolism and excess water. The 
kidney is composed of many tortuous uriniferous tubules which consist of two 
parts, the nephron, and the collecting duct. Nephron produces urine and the 
collecting duct concentrates the urine and passes out of the kidney to the ureter 
and urinary bladder. Each nephron is made up of a renal corpuscle, which filter 
the plasma, and a renal tubule, which selectively absorbs from the filtrate to 
form the urine. Collecting ducts transfer fluid from several renal tubules to a 
terminal papillary duct which inturn open into a minor calyx at the apex of a 
renal papilla. Papillary surfaces show numerous minute orifices of these ducts 
and pressure on a fresh kidney expresses urine from them. The ureters are 
muscular tubes whose peristaltic contractions convey urine from the kidneys to 
the urinary bladder (23). 
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Lower urinary tract (LUT): 
 
The Urinary Bladder: 
The urinary bladder is a reservoir. When empty, it lies entirely in the lesser 
pelvis but as it distends it expands antero-superiorly into the abdominal cavity. 
It has a base or fundus, neck, apex, a superior and two inferio-lateral surfaces. 
The base (fundus) of the bladder is triangular. In males it is related to the 
rectum and in females it is closely related to the anterior vaginal wall. 
The neck is the lowest region which is the most fixed part. It is 3-4 cm behind 
the lower part of the symphysis pubis. The bladder neck is the internal urethral 
orifice and alters little in position with varying conditions of the bladder and 
rectum. In males the neck is in direct continuity with the base of the prostate. In 
females, the neck is related to the pelvic fascia which surrounds the upper 
urethra. (23). 
 
As the bladder fills, it becomes ovoid and its fundus is only slightly depressed, 
as it is more or less fixed.  Its superior surface gradually rises into the 
abdominal cavity along with its peritoneal covering and round off the posterior 
and lateral borders. When the bladder is filled about 500ml, it assumes an oval 
form and is directed upward and forward. In females, the bladder is anterior to 
the uterus and the upper part of the vagina. When the bladder is empty, the 
uterus rests on its superior surface(21). 
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Interior of the Bladder   
Trigone is a small triangular area which consists of two different layers, 
superficial and deep trigonal muscles. The anterior angle of the trigone is formed 
by the internal urethral orifice and postero-lateral angles by the ureteral orifices. 
The mucous membrane lining the bladder is loosely attached to the muscular coat, 
and appears folded when the bladder is contracted and appears effaced when 
bladder is distended condition.  
Superficial trigone muscle becomes continuous with the smooth muscle of the 
proximal urethra in both sexes. In   male it extends along the urethral crest till the 
openings of the ejaculatory ducts(23). 
  
BLADDER NECK  
 
Bladder neck shall be dealt as a separate functional unit since the smooth muscle 
of the bladder neck is microscopically and pharmacologically distinct from the 
detrusor muscle proper. The arrangement of smooth muscle in bladder neck is 
quite different in males and females. In females, the bladder neck sits above the 
pelvic floor supported by the pelvic floor muscles and ligaments. When intra-
abdominal pressure rises, these muscles especially levator ani contract, increasing 
urethral closure pressure to maintain continence. In  males, the bladder neck is 
completely surrounded by a circular collar of smooth muscle and it stretches 
distally to surround the pre prostatic portion of the urethra(23) . 
The bladder is supplied by the superior, middle, and inferior vesical arteries, 
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which inturn are derived from the anterior trunk of the internal iliac artery. The 
obturator and inferior gluteal arteries also supply small visceral branches to the 
bladder. In females, additional branches are derived from uterine and vaginal 
arteries. The veins form a plexus on the infero-lateral surfaces and end in the 
internal iliac veins. The nerves of the bladder are fine myelinated fibers from the 
sacral nerves, and non-myelinated fibers from the hypogastric plexus. They are 
connected with intramural ganglia and distributed as non-myelinated fibers, to the 
muscular layer and epithelial lining.(24) 
 
Layers of the bladder  
 
The bladder has four layers: serous, muscular, submucous, and mucous coats. The 
serous layer is originated from the peritoneum. It invests the superior surface and 
the upper parts of the lateral surfaces, and is reflected from these on to the 
abdominal and pelvic walls.  
 
The muscular component consists of three layers of smooth muscular fibers: an 
external layer of longitudinal fibers; a middle layer of circular fibers; and an 
internal layer of longitudinal fibers. The fibers of the external layer are called the 
Detrusor muscle (8). The fibers of the middle circular layer are inclined in a 
thick circular layer, toward the lower part of the bladder forming the internal 
urethral sphincter. The internal longitudinal layer is slender, and its fasciculi 
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have a reticular arrangement. Two bands of oblique fibres which originate 
behind the orifices of the ureters unite to the posterior part of the prostate. These 
are the muscles of the ureters, and during the contraction of the bladder they help  
to retain the oblique direction of the ureters, and so avoid the reflux of the 
urine(24). 
 
The sub mucous coat is made of a layer of areolar tissue which connects together 
the muscular and mucous coats. The mucous coat is thin, smooth, and is 
continuous above through the ureters with the lining membrane of the renal 
tubules, and below with that of the urethra. The epithelium covering the mucosa 
is transitional epithelium. There are no true glands in the mucous membrane of 
the bladder.(24) 
 
THE URETHRA  
 
The male urethra extends from the internal urethral orifice in the urinary bladder 
to the external urethral orifice at the end of the penis. Its length varies from 18 to 
20 cm.It may be divided in two parts, long anterior urethra (16 cm) and short 
posterior urethra (4 cm).The anterior urethra is subdivided into a proximal bulbar 
urethra, which is surrounded by the bulbo spongiosus and a distal penile 
component, which continues till the tip of the penis. The posterior urethra has 
three parts namely preprostatic, prostatic, and membranous segments.  
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On the posterior wall or floor is a longitudinal ridge, the urethral crest or 
verumontanum. It contains muscular and erectile tissue. When distended, it may 
serve to prevent the retrograde passage of the semen into the bladder. On either 
side of the crest there is a slightly depressed prostatic sinus and the floor of this 
sinus is perforated by the prostatic ducts. Below its summit is a median 
elevation, the seminal colliculus, within the margins of which are the orifices of 
the prostatic utricle and the ejaculatory ducts. (24) 
 
The membranous portion is the shortest, and, with the exception of the external 
orifice, the narrowest part of the canal. It extends between the apex of the 
prostate and the bulb of the urethra, perforating the urogenital diaphragm. It 
measures about 2 cm. in length. The membranous portion of the urethra is 
completely surrounded by the fibres of the external urethral sphincter.  
 
The urethra is composed of mucous membrane, supported by a sub mucous 
tissue. The mucous membrane is continuous with the mucous membrane of the 
bladder,  ureters  and kidneys. Its epithelial lining is columnar except near the 
external orifice, where it is stratified squamous. The submucous tissue consists 
of a vascular erectile layer; outside this is a layer of unstriped muscular fibres, 
arranged, in a circular direction. (24) 
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The female urethra : 
The female urethra is a narrow membranous canal, about 4 cm. long, extending 
from the internal to the external urethral orifice. It is placed behind the 
symphysis pubis, imbedded in the anterior vaginal wall. Its external orifice is 
situated in front of the vaginal opening and about 2.5 cm. behind the glans of the 
clitoris. (24) 
 
MECHANISM AND CONTROL OF MICTURITION: 
Motor control of the lower urinary tract is by sympathetic, parasympathetic and 
somatic innervation, through the hypo gastric nerves, pelvic nerves, and the 
pudendal nerve respectively as shown in Figure 1. 
The sympathetic neurons are situated in the thoracolumbar spinal cord, with their 
axons in the hypo gastric and pelvic nerves.  The parasympathetic neurons are 
placed in the parasympathetic nucleus of the sacral cord. Their axons in the 
pelvic nerves synapse with postganglionic fibers in the intramural vesical 
ganglia.   
Somatic motor neurons in the Onuf’s nucleus are situated in the ventral horn of 
the sacral spinal cord, with their axons in the pudendal nerve and supply the 
external urethral sphincter. As the urine accumulates in the bladder during the 
storage phase, activation of the pudendal nerve sustain continence by contraction 
of the sphincter. 
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The sensory afferents from the bladder are predominantly the axons of small 
myelinated Aδ fibers or unmyelinated C fibers. Sensory afferents from the 
bladder  pass through the pelvic nerves with the cell bodies situated in the sacral 
dorsal root ganglia. Pontine micturition center mediate synergistic detrusor- 
external urethral sphincter function. Ponto-sacral integrity is essential for normal 
micturition control via interactions between the autonomic and somatic systems 
(25). 
 
Spinal neurons involved in the regulation of LUT function are located in the 
dorsal commissure, superficial dorsal horn and parasympathetic nucleus. 
Glutamate is the excitatory transmitter, while gamma amino butyric acid and 
glycine are inhibitory. (26). 
 
Supra spinal structures involved in micturition control are the medullary 
dorsomedial pontine tegmentum, also known as the pontine micturition center or 
the Barrington nucleus, the raphe nucleus, locus coeruleus, periaqueductal gray 
matter (PAG), hypothalamus and the medial frontal cortex. 
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Figure 1. Control of micturition 
 
 
The concept from animal studies that the lateral and medial parts of the pontine 
micturition center control the storage and voiding phases of micturition 
respectively have not been confirmed in human studies. From data obtained 
with Positron Emission Tomography (PET) and functional Magnetic Resonance 
Imaging (fMRI), brain regions activated during lower urinary tract function 
have been mapped and the “bladder control matrix” described (Figure 2). (27) 
During storage phase of micturition, afferent inputs reach the PAG and are 
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relayed via the hypothalamus and thalamus to the anterior cingulate cortex, to 
the insula, and to the prefrontal cortex. The prefrontal cortex, hypothalamus, 
insula, and anterior cingulated cortex inhibit the PAG thereby inhibiting the 
pontine micturition center. When a decision to void is made, PAG inhibition by 
the prefrontal cortex is interrupted, the hypothalamus stimulates the PAG , in 
turn exciting the pontine micturition center which sends excitatory motor 
signals to the sacral spinal cord causing contraction of the detrusor and 
relaxation of the urethra.(27)  
Receptors and Neurotransmitters  
The bladder contains cholinergic muscarinic and nicotinic receptors and α- and 
β-adrenergic receptors. The receptors active during bladder contraction are 
cholinergic muscarinic (M2 and M3) receptors widely distributed in the body of 
the bladder, trigone, bladder neck, and urethra. The M2 receptors predominate 
structurally in normal bladders, but the M3 receptors might be more important 
functionally. The cholinergic nicotinic receptors are primarily located in the 
striated sphincter. (25)  
 
Adrenergic receptors are concentrated in the trigone, bladder neck, and urethra 
and are predominantly α1. These have recently been subdivided into α1a, α1b, 
and α1d. Identification of these α1 subgroups could allow increased specificity 
with regard to therapeutic agents. Norepinephrine-containing nerve cells are 
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also found in the paravesical and intramural ganglia. When these cells are 
active, they have excitatory effects and maintain continence by contraction of 
the bladder neck and urethral smooth muscle. β2- and β3-adrenergic receptors 
are found in the bladder neck and also in the body of the bladder. These 
receptors are inhibitory when activated and can produce relaxation at the 
bladder neck on initiation of voiding and relax the bladder body to enhance 
storage. In humans, the storage role seems to be a minor one for the adrenergic 
system. Other lower tract transmitters have been considered, but the role of 
these other transmitters in normal and disease states in humans is uncertain 
(25).  The main effector transmitter for contraction of the urethra is 
norepinephrine, via the α1 receptors. Smooth muscle relaxation is mediated by 
the effects of acetylcholine in the pelvic ganglia. This releases nitric oxide in 
the urethral wall, resulting in relaxation of urethral smooth muscle. 
Prostaglandins, in contrast to their effects on the detrusor, cause a relaxation of 
the urethral muscle. Serotonin appears to be an antagonist that causes urethral 
muscle contraction. It might be important in the production of irritable urethral 
symptoms. The role of estrogens on the lower urinary tract in women is 
confined to the modification of tissues and receptors (25). 
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Figure 2: Bladder Control-Central Mechanism 
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In the brainstem and spinal cord the various transmitters can have a variety of 
inhibitory and facilitative actions, depending on their site of action. Serotonin might 
have inhibitory detrusor effects at the midbrain level, and uptake of serotonin might 
be blocked by tricyclics (used in treating nocturnal enuresis). Activation of opiate 
receptors in the brainstem and sacral spinal cord inhibits voiding, which might 
partly explain the retention of urine seen with the use of these agents. Serotonin and 
nor epinephrine reuptake inhibitors prolong the effect of these agents in the 
synaptic cleft of Onuf ‘s nucleus and increase the activity of the external sphincter 
(28). 
 
Neurogenic bladder in Spinal Cord Injury 
The primary mechanism of impairments due to spinal cord injury, either traumatic 
or non-traumatic is the interruption of ascending and descending tracts between the 
spinal cord and supraspinal centers. The injured neuronal processes undergo 
Wallerian degeneration, and glial cells initiate the synthesis of a scar at the site of 
injury, which might prevent growth of the injured neural processes.(29) The 
consequences of spinal cord injury on lower urinary tract function depend on the 
etiology, level, duration, and severity of the lesion. Following cervical and thoracic 
level spinal cord injuries, there is usually a period of bladder areflexia and urinary 
retention, the duration of which depends on the spinal shock which varies from a 
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few hours to many weeks (30). Normally, initiation of micturition is by activation 
of low-threshold Aδ fibers. When the micturition reflex emerges post spinal injury, 
the reflex is dependent on high-threshold capsaicin-sensitive C-fibers. It has been 
demonstrated that intravesical capsaicin reduces bladder over activity (31).The 
micturition reflex is ineffective in adequately emptying the bladder due to detrusor-
sphincter-dyssynergia, which is defined as a detrusor contraction concurrent with 
an involuntary contraction of the urethral and/or periurethral striated muscle 
(32)This may cause large residual volumes of urine and bladder hypertrophy 
resulting in high intravesical pressure, which might predispose to long term upper 
urinary tract complications and episodes of autonomic dysreflexia. (33,34) 
 
The neurogenic bladder has been classified in a variety of ways, beginning with the 
anatomic classification of Bors and Comarr. The functional classification was 
based on cystometric findings, and five basic groups namely reflex, uninhibited, 
autonomous, motor paralytic, sensory neurogenic were described.  
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Table 3-Functional Classification of the Neurogenic Bladder:  
  
Type of Failure  
 
Bladder Factors  
 
Outlet Factors  
 
Failure to store  
 
Detrusor overactivity  
 
Denervated pelvic floor  
 
Decreased compliance  
 
Bladder neck descent  
 
 Intrinsic bladder neck sphincter 
failure  
 
Failure to empty  
 
 
Acontractile detrusor  
 
Detrusor–sphincter dyssynergia  
 
Hypocontractility  Nonrelaxing voluntary sphincter  
 
 Mechanical obstruction (Benign 
prostatic hypertrophy or stricture)  
 
 
 
Functional classification is based on conventional urodynamic evaluations to 
categorize the lower urinary tract according to the passive storage ability of the 
bladder and the activities and coordination of the detrusor and sphincter 
mechanisms. In practice it is common to use a combination of both anatomic and 
functional classifications. Clinical management is based on functional changes 
demonstrated by urodynamic testing(35).  
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Figure 3- Anatomic classification 
 
 
EVALUATION OF NEUROGENIC BLADDER: 
  
Evaluation of neurogenic bladder should begin with a careful history and physical 
examination.  
 
Lower urinary tract symptoms- classification  
International Continence Society Standardization of Terminologies in Lower 
urinary tract function, 2002, classified the lower urinary tract symptoms in terms of 
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storage symptoms or voiding symptoms or post micturition symptoms (32).  
Storage symptoms  
Storage symptoms are those experienced during the storage phase of the bladder. 
Symptoms relevant to neurogenic bladder are as follows. Urgency is the complaint 
of a sudden compelling desire to pass urine which is difficult to defer. Urinary 
incontinence is the complaint of any involuntary leakage of urine.  
Stress urinary incontinence is the complaint of involuntary leakage on effort or 
exertion, or on sneezing or coughing. Urge urinary incontinence is the complaint of 
involuntary leakage accompanied by or immediately preceded by urgency. 
Continuous urinary incontinence is the complaint of continuous leakage.  
Bladder sensation can be defined by five categories.  
Normal: the individual is aware of bladder filling and increasing sensation up to a 
strong desire to void.  
Increased: the individual feels an early and persistent desire to void.  
Reduced: the individual is aware of bladder filling but does not feel a definite desire 
to void.  
Absent: the individual reports no sensation of bladder filling or desire to void.  
Non-specific: the individual reports no specific bladder sensation but may perceive 
bladder filling as abdominal fullness, or spasticity. 
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Voiding Symptoms  
Voiding symptoms are experienced during the voiding phase. Symptoms relevant to 
neurogenic bladder are as follows.  
Hesitancy is the difficulty in initiating micturition resulting in a delay in the onset 
of voiding after the individual is ready to pass urine. Straining to void describes the 
muscular effort used to initiate, maintain or improve the urinary stream. Terminal 
dribble is the term used when an individual describes a prolonged final part of 
micturition, when the flow has slowed to a trickle/dribble.  
 
Post micturition symptoms  
These are experienced immediately after micturition. Feeling of incomplete 
emptying is a self-explanatory term for a feeling experienced by the individual after 
passing urine. Post micturition dribble is the term used when an individual 
describes the involuntary loss of urine immediately after passing urine, usually after 
leaving the toilet in men, or after rising from the toilet in women.  
 
Lower urinary tract pain symptoms  
Pain, discomfort and pressure are part of a spectrum of abnormal sensations felt by 
the individual. Pain produces the greatest impact on the patient and may be related 
to bladder filling or voiding, may be felt after micturition, or be continuous. Pain 
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should also be characterized by type, frequency, duration, precipitating and 
relieving factors and by location. Bladder pain is felt suprapubically or 
retropubically, and usually increases with bladder filling, it may persist after 
voiding. Urethral pain is felt in the urethra, the individual indicates urethra as the 
site. Scrotal pain may or may not be localized, for example to the testis, 
epididymis, cord structures or scrotal skin. Perineal pain is felt in females between 
the posterior fourchette and the anus, and in males between the scrotum and the 
anus. (32). 
Presenting symptoms  
The symptomatology varies depending on the pathology causing the neurogenic 
bladder- the aetiology, the site and the extent of injury, duration of injury and 
neurologic recovery following the initial trauma.  In the upper motor type of 
neurogenic bladder, once the spinal shock phase is over, apart from varying degrees 
of impaired bladder sensation and ability to void, the symptoms would tend to be 
those related to intact sacral reflex arc- intermittent non-stress urinary incontinence, 
hesitancy, urgency, straining, interrupted or diminished stream, sensation of 
incomplete emptying. In lower motor type of neurogenic bladder, apart from 
varying degrees of impaired bladder sensation, the symptoms would tend to be 
those related to impaired sacral reflex arc- inability to void normally, stress urinary 
incontinence, necessity to apply abdominal pressure/suprapubic pressure/ Crede’s 
manoeuvre to empty the bladder. Apart from these, there could be 
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history/symptoms of pressure ulcers related to inadequate perineal hygiene, 
symptoms of recurrent urinary tract infections such as intermittent high grade fever, 
chills, nausea, vomiting, urinary sediments, loss of appetite, and pyuria. The history 
should include the following premorbid voiding pattern ,lower urinary tract 
symptoms ,bladder sensation ,incontinence ,type of voiding- mode, frequency, 
difficulties, relevant review of systems.(36)  
 
Clinical  examination  
A careful neuro-urological examination is warranted, including the sacral 
dermatomes for perianal sensation, anal sphincter tone, voluntary anal contraction 
and the bulbocavernosus reflex. Deep tendon reflexes in the lower extremities, 
clonus, and plantar response should also be evaluated. (25) 
 
Bladder diary  
Maintaining a bladder diary is a very essential step in the evaluation of a 
neurogenic bladder. A micturition time chart documents the time of each 
micturition. The voided volumes are documented in a frequency volume chart. The 
bladder diary adds to this the relevant symptoms and problems such as urgency, 
pain, incontinence episodes, and pad usage. Recording for a minimum of 2 days is 
suggested. From the recordings, the average voided volume, voiding frequency, and 
if, the patient’s time in bed is recorded, day/night urine production and nocturia can 
32 
 
be determined. This information give objective verification of the symptoms, and 
provides values for control of subsequent urodynamic studies to prevent over-
filling of the bladder (35).  
 
Diagnostic Tests: 
The lower urinary tract evaluation can be simple, from urine analysis to urine 
culture to measurement of postvoid residual. A full urodynamic evaluation might 
be necessary if incomplete bladder emptying, incontinence, recurrent bacteriuria, or 
upper tract changes are present. The bladder findings on urodynamic studies cannot 
be used alone to determine the level of neurologic lesion. For example, a 
suprasacral neurogenic bladder from a complete spinal cord injury can remain 
areflexic, and a conal or cauda equinal bladder can exhibit high pressures from poor 
compliance. Although the anatomic level of the neurologic lesion can suggest the 
most likely pattern of bladder dysfunction, urodynamic testing should be performed 
to confirm this. Functional bladder studies in traumatic spinal cord injury are best 
deferred until spinal shock has cleared(30).    
 
Upper Tract Tests  
Plain Radiography of the Urinary Tract—Kidneys, Ureter, and Bladder(KUB)  
KUB study is often combined with USG to identify any possible radiopaque calculi 
in the ureter or bladder stones not seen on USG.  
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Ultrasonography  (USG) 
It is a low-risk and relatively low-cost test for routine evaluation of the upper 
urinary tract that is easy for the patient as well. It is not sensitive enough to evaluate 
acute ureteral obstruction.Ultrasonography is adequate for imaging chronic 
obstruction and dilation, scarring, renal masses (both cystic and solid), and renal 
stones. The ureter is seen on ultrasonography imaging only if dilated. The bladder, 
if partially filled, can be evaluated for wall thickness, irregularity, and the presence 
of bladder stones.  
Excretory Urography/ Computed Tomography/ Intravenous Pyelogram  
A CT without and then with intravenous contrast, with a delayed plain KUB film, 
has largely replaced the excretory urogram. If the serum creatinine concentration is 
more than 1.5 mg/dL, or if the patient has insulin-dependent diabetes, intravenous 
contrast agent administration increases the risk of contrast-related nephropathy. In 
these cases, alternative studies include US, radioisotope renography, and 
cystoscopy with retrograde pyelography (35).  
Creatinine Clearance Time 
 This has been the gold standard for assessing renal function and is said to 
approximate the glomerular filtration rate (GFR)(35). Its accuracy depends on 
meticulous urine collection. It can also be misleading in some clinical situations as 
in tetraplegics with low muscle mass. In view of this, markers like serum cystatin C 
are being studied.  
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Lower Tract Tests  
Urinalysis, Culture and Sensitivity Testing  
These are done routinely for all patients with neurogenic bladder disease and 
should be repeated as necessary. These would also be recommended before 
invasive procedures in cases of symptomatic urinary tract infections or with new 
lower urinary tract symptoms such as incontinence, frequency, etc. Bacteriuria 
should be treated before any invasive urologic procedure or test is performed.(35) 
Symptomatic UTI can be  defined using CDC criteria(Table-4)  
 
Urine dipstick test 
Urine dipstick testing can be used as a screening test for detecting various disorders 
in the areas of metabolic and renal disorders.  It is nowadays used in the detection 
of UTI .(37) A chemically impregnated reagent strip is dipped in fresh urine to 
determine specific gravity, pH, blood, glucose, ketones, bilirubin, protein, 
urobilinogen, nitrites, and leukocyte esterase. 
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      Table 4- CDC criteria for symptomatic UTI 
 
1.A positive urine culture of ≥105 colony-forming units (CFU)/ml with no 
more than 2 species of microorganisms 
AND 
at least 1 of the following signs or symptoms with no other recognized 
cause:  
fever (>38°C), urgency, frequency, dysuria, suprapubic tenderness, or 
costovertebral angle pain or tenderness 
  
2. A positive urine culture of ≥103 and <105 CFU/ml with no more than 2 
species of microorganisms 
 
AND 
at least 1 of the following signs or symptoms with no other recognized 
cause:  
fever (>38°C), urgency, frequency, dysuria, suprapubic tenderness, or 
costovertebral angle pain or tenderness  
 
AND 
 
at least 1 of the following findings:  
a. positive dipstick for leukocyte esterase and/or nitrite  
b. pyuria (urine specimen with ≥10 white blood cells [WBC]/mm3 of 
unspun urine or ≥3 WBC/high power field of spun urine)  
c. microorganisms seen on Gram stain of unspun urine  
 
CDC criteria for detecting UTI utilises nitrite and leukocyte esterase. The test is 
specific for nitrite and will not react with any other substance normally excreted in 
the urine. This test depends upon the conversion of nitrate (derived from the diet) to 
nitrite by the action of Gram negative bacteria in the urine. Nitrite from the urine 
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reacts with para-arsanilic acid to form a diazonium compound, at the acid pH of the 
strip. This diazonium compound in turn couples with 1,2,3,4 - 
tetrahydrobenzo(h)quinolin-3-ol to produce a pink colour. The proportion of 
positive nitrite results in cases of significant infection depends on how long the 
urine was retained in the bladder prior to collection. 
Leukocyte Esterase is generally negative in normal urine specimens. Positive 
results (small or greater) are clinically significant. Individually observed trace 
results may be of questionable clinical significance.´ Trace’ results observed 
repeatedly may be clinically significant. Positive results may occasionally be found 
with random specimens from females due to contamination of the specimen by 
vaginal discharge. 
Post void Residual  
The volume of bladder immediately following voiding is an indicator of quality of 
voiding, and is a simple tool to assess lower urinary tract symptoms (38).By itself, a 
low postvoid residual (PVR) of less than 20% of capacity is not indicative of a 
balanced bladder because high intravesical pressures can be present despite low 
PVR values. The PVR is simple to determine and clinically useful, especially when 
compared with previous recordings and considered in conjunction with the bladder 
pressure, clinical symptoms, and the appearance of the bladder wall. PVRs can vary 
throughout the day. A catheter insertion has been used for PVR, but 
ultrasonography is preferred to noninvasively obtain the PVR (25) 
37 
 
 
Cystography  
This is performed to test for the presence or absence of vesicoureteric reflux. 
Modalities of conducting a Cystography include retrograde Cystography, voiding 
cystourethrography, radionuclide cystography (39)It also shows the outline and 
shape of the bladder. In many cases a videourodynamic study, which includes 
fluoroscopy of the bladder and monitoring of the intravesical pressure, is more 
clinically useful.  
 
Cystometrography (CMG) 
CMG is a filling study and gives little information about the voiding phase of 
bladder function. It has a two-channel catheter, with one channel used for filling 
and the other for pressure recording. A rectal pressure trace is used to distinguish 
intravesical pressure variations (resulting from intra-abdominal transmission) from 
contractions of the detrusor itself. Filling rates vary but usually range from 20 to 
100ml per minute. Normal values include a capacity of 300 to 600 mL, with an 
initial sensation of filling at approximately 50% of capacity. The sensation of 
normal fullness is said to be appreciated in the lower abdomen with a sense of 
urgency in the perineum. The change in volume divided by the increase in baseline 
pressure during filling (i.e., in the absence of a detrusor contraction) describes the 
bladders compliance. This value should be greater than 10 mL/cm H2O, and 10 to 
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20 mL/cm H2O is considered borderline if the bladder capacity is reduced. Any 
involuntary detrusor contraction during the test, usually defined as any appreciable 
phasic pressure change, is abnormal. If the patient has a suprasacral or supraspinal 
lesion, these contractions are called neurogenic detrusor overactivity.  
 
The CMG is a useful test to monitor the return of a detrusor reflex in the spinal 
shock phase of spinal cord injury, and to confirm the presence of detrusor 
hyperactivity in patients with supraspinal or cerebral insult before pharmacotherapy 
is started (25). 
 
Sphincter electromyography (EMG) can be combined with the CMG. Recordings 
have been made with a variety of electrodes (needle and surface electrodes) from 
the levator, perianal, or periurethral muscles (40). The integrated EMG is displayed 
on the same trace as the bladder pressure. EMG activity gradually increases as 
bladder capacity is reached during bladder filling, and then becomes silent just 
before voiding. Low levels of EMG activity with no recruitment during filling are a 
common pattern in complete spinal cord injury. When a reflex detrusor contraction 
occurs in these patients, the EMG activity in the sphincter can increase rather than 
decrease. With this detrusor–sphincter dyssynergia, voiding often occurs toward the 
end of the detrusor contraction because the striated sphincter relaxes more quickly 
than the smooth muscle of the bladder.  
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Cystoscopy  
The only routine indication for cystoscopy is the presence of a long-term 
indwelling suprapubic or urethral catheter because the presence of the catheter 
increases the risk for bladder tumour development, which has been reported to be 
about 0.39% among persons with SCI (41)Cystoscopy is recommended after 5 
years in high-risk patients, such as smokers, or after 10 years in those with no risk 
factors. Cystoscopy should also be performed after CT– intravenous pyelography 
(CT-IVP) in patients who have gross or microscopic hematuria that cannot be 
clearly associated with UTI, stones, or trauma. Repeated lower tract infections can 
be an indication for cystoscopy and can reveal non-opaque foreign bodies, such as 
hairs, that have been introduced by catheterization (25) 
 
Uroflowmetry measures the flow rate of the external urinary stream as volume per 
unit time in milliliters per second (ml/s). It is a non-invasive and relatively 
inexpensive investigation. Therefore, it is an indispensable, first-line screening test 
for patients with lower urinary tract symptoms who can void (42) 
The results from uroflowmetry should be compared with the data from the patient’s 
own recording on a frequency/volume chart. USG estimation of post-void residual 
volume completes the noninvasive assessment of voiding function (43) 
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Video-urodynamics  
This study is designed to give the maximum information about the filling and 
voiding phases of lower urinary tract function. A video-urodynamic study is 
indicated in those with incontinence, those who void voluntarily but empty 
incompletely, persons with mechanical obstruction with neuropathy, and candidates 
for sphincterotomy. Video-urodynamics is useful to assess detrusor contraction and 
the presence or absence of bladder neck obstruction, in addition to external urethral 
sphincter dyssynergia. (25) 
 
MANAGEMENT OF NEUROGENIC BLADDER  
Management strategies for neurogenic bladder following spinal cord injury involve 
interventions to promote storage of urine, to facilitate bladder emptying, while 
maintaining social continence (44)This includes lifestyle modifications, 
pharmacological and surgical interventions. Commonly used method when there is 
inadequate bladder emptying due to spinal cord injury consists of reducing the 
overactivity of the detrusor if present, and promoting emptying of the bladder by 
clean intermittent catheterization (CIC). This has become the standard management 
method for individuals with SCI and comprises several advantages, including 
improved quality of life (3). 
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Behavioral Management  
Timed Voiding  
For patients with hyperactivity producing urgency or reflex incontinence, a timed 
voiding program can help by having the patient urinate before the anticipated 
detrusor contraction. The limitation to this program is that persons with dementia 
need continual reminding. It is also useful in patients with sphincter weakness 
because the incontinence is worse when the bladder is full, and timed voiding 
reduces the amount of urine leakage. This can be combined with monitoring fluid 
intake patterns and educating the patient in the relationship between fluid intake 
and urine output.  
 
Bladder Stimulation  
Various maneuvers have been tried to stimulate the bladder. Stroking or pinching 
the perineal skin to cause reflex stimulation is only rarely effective. Suprapubic 
tapping or jabbing over the bladder causes a mechanical stretch of the bladder wall 
and subsequent contraction. Controlled studies have shown that deeper indentation 
of the bladder with a jabbing technique is the most effective maneuver. This can be 
used by spinal cord–injured patients with condom catheters. It is most effective in 
patients with paraplegia who have good upper limb function (45). 
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Valsalva and Crede Maneuvers  
Patients with areflexia and infrasacral lesions are able to void by doing a Valsalva 
maneuver or straining. Complete flaccidity of the pelvic floor can allow emptying 
by straining. The Crede maneuver mechanically pushes urine out of the bladder. 
The abdominal wall must be relaxed to allow the Crede maneuver to be effective. 
Crede maneuver is reported to be superior to continuous bladder catheterization in 
long-term use (46) 
 
Anal Stretch Voiding  
In patients with paraplegia who have a spastic pelvic floor, effective voiding has 
been achieved by an anal stretch technique. This technique involves relaxing the 
pelvic floor by first stretching the anal sphincter and then emptying the bladder by 
the Valsalva maneuver ((25) 
 
Urine Collection Devices  
External Condom Catheters are convenient and often the best management for men 
with tetraplegia who are unable to perform self-catheterization, provided that any 
outflow obstruction is adequately treated. Problems with skin breakdown and 
urethral damage can occur if the condom is applied too tightly. An increased risk of 
UTI can result from poor hygiene.  
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Indwelling Catheters can be either urethral or suprapubic and are typically used 
either because other programs have failed or for patient convenience. Important 
aspects of care include monthly catheter changes, copious fluid intake, control of 
hyperactivity, and avoidance of traction on the catheter. The prevalence of 
squamous cell carcinoma of the bladder associated with an indwelling catheter 
might be lower than reported.  
Adult Diapers and Other Protective Garments have a high-absorbency gel-
impregnated material that allows the lining against the patient’s perineal skin to 
stay dry. Protective garments are commonly used in incontinent patients with 
dementia who have adequate bladder emptying.  
 
Clean Intermittent Catheterization  
Clean Intermittent Catheterization is a technique of bladder care where the patient 
or the caretakers do catheterization in timed intervals in a clean manner. ICC is now 
generally accepted to be the best and safest long-term bladder method for spinal 
cord injury patients. This technique has several advantages & some disadvantages. 
This study deals with need of antibiotic prophlaxis during the initiation of ICC. 
Hence a detailed discussion on ICC & various studies regarding it will be discussed 
in the following part of this dissertation. 
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Medications  
Many drugs for lower urinary tract management have been tried, with the most 
effective groups are those that inhibit detrusor activity.  
Anticholinergic Agents  
Anticholinergic agents have been used for the optimization of detrusor over 
activity. While propantheline bromide and hyoscyamine have been used. 
Oxybutynin is currently the most commonly used agent. Oxybutynin hydrochloride 
can be taken at up to 5 mg four times a day or sustained release 15 mg once or 
twice daily in patients with no renal impairment concerns. Lower doses are needed 
in patients with severe hepatic impairment. Oxybutynin in solution can be 
administered as an intravesical instillation in patients requiring intermittent 
catheterization. The side effects include mostly dry mouth and constipation, and 
appear to be less severe than when the drug is given orally (47). An oxybutynin 
transdermal preparation is also available, although skin irritation might limit its use. 
Tolterodine is a muscarinic receptor antagonist used at a dose of 2 mg twice daily 
or 1 mg twice daily for patients with severe renal or hepatic impairment. 
Darifenacin, a newer muscarinic receptor antagonists is available as an extended 
release tablet (7.5 to 15 mg daily), which binds M3 receptors to a much greater 
extent. Solifenacin is available at 5 to 10 mg daily. Trospium is used at a dose of 20 
mg twice daily or sustained release at 60 mg daily. Major side effects include dry 
mouth, blurry vision and constipation (48) 
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Adrenergic Antagonists  
The α1-adrenergic receptor blocking agents prazosin, terazosin, and doxazosin 
increase emptying in patients with neurogenic voiding dysfunction. Tamsulosin 
(0.4 to 0.8 mg daily) has fewer vascular effects and rarely causes hypotension. It 
improves bladder storage and emptying and decreases the symptoms of autonomic 
dysreflexia (49). All of these agents are effective in control of the vascular 
manifestations of autonomic dysreflexia  
 
Adrenergic Agonists  
Adrenergic agonists have been used to increase urethral resistance in patients with 
mild stress incontinence. Ephedrine (25 to 75 mg/day) has been effective in 
controlling mild stress incontinence in children with myelodysplasia. Prolongation 
of the α-adrenergic effects on the external urethral sphincter could be possible in 
the future using duloxetine, a serotonin and nor epinephrine reuptake inhibitor, 
which acts on the pudendal (Onuf‟s) nucleus in the sacral cord (28) 
 
Estrogens  
Postmenopausal women often have atrophy of the urethral sub mucosa, which can 
lead to stress incontinence.  Estrogen administration by local application often 
restores or maintains this tissue and can be helpful in such women with 
incontinence (50) 
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Muscle Relaxants  
Baclofen, tizanidine, and dantrolene sodium are frequently used for skeletal muscle 
spasticity but have never been shown to be effective in controlled studies in patients 
with detrusor-striated sphincter dyssynergia.  Baclofen given intrathecally by 
infusion pump for severe lower extremity spasticity depresses pelvic floor reflexes 
but also depresses the detrusor reflex and has limited effect in improving voiding in 
overactive bladder (51) 
 
Intravesical Therapy  
Botulinum A toxin, given by injection at 30 to 40 sites in the bladder wall up to a 
total dose of 200 units, reduces or abolishes hyperactivity for up to 6 months. 
Repeated injections can be given. Although botulinum toxin-A is widely available, 
it is an off-label use (52). Intravesical resiniferatoxin instillations have also shown 
effectiveness in improving symptoms of overactive detrusor (53).  
 
Surgery  
Bladder augmentation is often recommended for patients who have detrusor 
hyperactivity or reduced compliance that fails to respond to anticholinergic drugs. 
The procedure is intended to result in a low-pressure reservoir. The long-term 
complications reported so far have included chronic bacteriuria, a theoretical risk of 
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neoplastic change, possible diarrhea or malabsorption from a shortened gut or 
decreased intestinal transit time. High level of patient satisfaction by the 
achievement of the primary aim of ensuring continence and upper tract safety 
seems to outweigh the complications (54) 
 
Continent Diversion  
A section of bowel is used to increase effective bladder capacity and to form a 
continent catheterizable channel that opens onto the abdominal wall. Individuals 
who are unable to perform intermittent catheterization because of strictures, false 
passages, or fistulas are potential candidates (55). The terminal ileum and the 
ileocecal valve, intussuscepted small bowel, the appendix, a defunctioned segment 
of ureter have all been used. The bladder neck might require closure if there is 
sphincter-related incontinence.  
 
Denervation Procedures  
Operative approaches for denervation procedures include sectioning of the sacral 
nerve roots or interrupting the peripheral nerve supply near the bladder. Selective 
sacral rhizotomy involves identifying and blocking the nerve root, usually S3, 
which mediates the detrusor reflex (56). Surgical or chemical destruction of S3 
usually results in only temporary areflexia. Over time the detrusor reflex typically 
reroutes through the intact sacral nerves. Bilateral S2, S3, and S4 rhizotomies 
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permanently abolish the reflex but at the expense of loss of reflex erections and 
worsening of the bowel evacuation problem.  
Peripheral denervation of the detrusor has been attempted by transecting the 
detrusor above the trigone and resuturing it, by removing the paravesical ganglia 
via a vaginal approach, or by overdistending the bladder with the intent of 
damaging the intramural nerves and muscle fibers. None of these peripheral 
denervation procedures have become commonly accepted, and long-term results of 
intentional over-distention of the bladder in spinal shock have not yet been reported 
(25). 
 
Procedures to increase bladder contraction  
Electrical Stimulation  
Techniques to modulate detrusor contraction have been attempted using electrodes 
implanted on the bladder wall, pelvic nerves, sacral roots, and conus. The 
electrodes are placed on the anterior roots either intradurally or extradurally. To 
prevent spontaneous hyperactive contractions and antidromic reflex contractions, 
bilateral S2, S3, and S4 dorsal rhizotomies are usually performed. Further 
refinements such as super-selective rhizotomies, with modification of stimulus 
parameters and electrode design, are future possibilities (25) 
 
 
49 
 
Procedures to increase outlet resistance  
Severe incontinence resulting from decreased outlet resistance can be managed by 
urethral compressive procedures. The options include injection therapy into the 
bladder neck and urethra to increase the bulk of tissue under and around the bladder 
neck muscle, a fascial sling, or an artificial sphincter (57).Electrical stimulation of 
pelvic floor muscles or nerves via rectal, vaginal, or implanted electrodes has been 
tried but has not been effective enough.  
Injection Therapy  
Injections of Teflon have been used for years in the urethra for certain types of 
stress incontinence, but their use has recently declined because of the danger of 
particle migration. Autologous fat and bovine collagen have also been tried. The 
procedure has few potential side effects and is especially suitable for elderly and 
poor-risk patients (58). 
External Compressive Procedures  
In the fascial sling procedure, a 2-cm strip of fascia is taken from the anterior rectus 
abdominis fascia or tensor fascia lata. It is wrapped around the bladder neck and 
fixed anteriorly to the abdominal fascia or pubic tubercle. Patients who are 
candidates for this procedure must have compliant low-pressure bladders. They will 
be unable to void by the Valsalva maneuver after a successful sling procedure and 
must be willing to perform self-catheterization.  
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The artificial urinary sphincter consists of a cuff, a pressure-regulating balloon, and 
a control pump. The cuff is usually implanted around the bladder neck. The pump 
in the labia or scrotum allows the patient to open the cuff for voiding. Patients can 
use the Valsalva maneuver to void and do not usually have to be on self-
catheterization. Artificial sphincters have been reported to have a positive impact 
on the quality of life (59) 
 
Procedures to decrease outlet resistance  
Sphincterotomy  
In male spinal cord–injured patients unable or unwilling to do self-catheterization, 
the use of a condom catheter is a practical alternative. Ablation of the striated 
sphincter, usually by incision, is the standard procedure. Older men with prostatic 
obstruction might require prostatic resection. The long-term results can be 
compromised because of recurrent obstruction from stricture or recurrent 
dyssynergia (60). 
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Intermittent clean catheterization 
Intermittent catheterization was first described by Teevan in 1880. The technique 
was used by patients with flaccid bladder dysfunction related to neurological 
complications of syphilis in England. Patients were said to carry their catheters in 
their hat bands(61). 
 In the 1950s Guttmann and Frankel commenced Intermittent catheterization using 
a sterile no touch technique for the management of patients with acute spinal cord 
injury. Sterile materials, sterile gloves and forceps were used to prevent “infection”. 
In the initial use of the technique during a bladder training program catheterization 
was done only by a catheter team. This was proven to obtain a very low infection 
rate. Nowadays the sterile technique is mostly used only during a restricted period 
of time and in a hospital setting. In the majority of cases a clean technique is used. 
Intermittent catheterization can be a lifesaving technique by reducing the risk of 
upper urinary tract deterioration and urosepsis in spinal cord patients.(62) 
Intermittent catheterisation can be in different types. 
1. “Clean Intermittent Self catheterisation” (CISC) – in this procedure patient 
himself passes a catheter into the bladder in regular timings, say 4-6 times a day, to 
assist in the clearance of urine where normal voiding is not feasible. This is a 
clinically clean procedure. 
2. "Intermittent Catheterisation" – similar to CISC. Only difference is that here the 
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procedure is done by the relative or carer, always with full consent from the patient. 
In the above two methods it is worthwhile that good hand washing training is 
described and demonstrated to the person or care take who will be performing the 
technique. 
3.”Sterile Intermittent catheterisation “is generally performed in acute or 
emergency circumstances to alleviate urinary retention.  Here catheterisation must 
always be done under sterile conditions. This may be done  prior to the future 
management of the patient's bladder problem being decided.(63)  
Lapides reintroduced clean intermittent catheterization in the early winter of 1970 
to a 30-year old woman with diurnal incontinence and frequent urinary tract 
infections secondary to neurogenic bladder from multiple sclerosis. According to 
Lapides , host resistance factors were adequate to check symptomatic urinary 
infection provided the bladder was emptied regularly. The acknowledgment that 
sterility of the catheter was insignificant was given by the patient herself. This is 
because while traveling in Europe the patient put her sterile catheter on the floor of 
a public restroom and, incapable to re-sterilize it, she just continued with her 
catheterization with no bad effects .This techniques revolutionized the management 
of neurogenic bladder conditions. Lapides et al. in 1972 published more clinical 
results of CIC and proposed this  nonsterile, clean technique for the management of 
chronic retention and infection (15).The technique is now extensively used for 
neurogenic bladder disease.  
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ICC can also be used for the treatment of urethral stricture due to narrowing of the 
urethra resulting from scarred healing after an infection (urethritis) or 
trauma.(64,65)ICC can also be used for the management of incomplete bladder 
evacuation or urinary retention and  measurement of residual urine if a Ultrasound 
machine is not available.(63,66) It  may also be used for instillation of drug into the 
bladder.(67)ICC can be used in the management of a urinary pouch proposed by 
Mitrofanoff  Norton, 1996.(68)  
 
Age is not a barrier for carrying out ICC. Children as young as 5years can be taught 
and /or a parent of younger children can learn to catheterise their child.(63) 
Although there are occasional situations where acceptable measures can be made 
for intermittent catheterization to be executed by care takers rather than the patient, 
in a good number of situations such an deal is socially unacceptable. Therefore, 
intermittent catheterization is generally done by the patient themselves using a 
clean technique – clean intermittent self-catheterization (CISC). The successful 
long-standing use of the method is reliant on patient enthusiasm as the managing 
system does occupy a level of difficulty. 
In acute spinal cord injury, patients are usually in spinal shock, with the bladder 
being areflexic, retaining urine. This in most cases resolves after 6 - 12 weeks and 
during this period indwelling catheter is the initial management option to remove 
urine and observe output. Patients can be started on an intermittent catheterization 
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program, when they can bear a fluid restriction of around 2 Litres per day. The goal 
is to have a “balanced bladder” that includes maintaining low bladder pressures and 
continence while minimizing infections and the risk of upper tract 
deterioration(69,70). For patients with an UMN injury who have satisfactory hand 
function, an IC program gives a near physiologic micturiton pattern.  
 It is highly advantageous that the patient should be constantly continent with 
enough outflow resistance and have a bladder that stores a sufficient volume of 
urine (300 ml or more) at low pressure. As a result the urologist may have to treat 
neurogenic detrusor hyper activity in a patient with a supraconal SCI or have to 
deal with reduced bladder compliance and/or stress incontinence in a patient with a 
conus injury. Choices for taking care of detrusor hyperactivity include 
anticholinergic medication orally or intravesically, botulinum toxin injections 
intravesically, augmentation cystoplasty or rhizotomy of the dorsal roots of S2, 3, 
4. If the bladder is not adequately acontractile, anticholinergics can be used. If these 
do not succeed, surgical intervention such as augmentation can be done to attain a 
low-pressure reservoir. At least 3-4 catheterizations per 24 hours are suggested 
because longer breaks between catheterizations theoretically add to the risk of 
symptomatic bacteriuria. A totally sterile technique can also be used but is not often 
done in clinical practice(71) 
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Anticholinergic drugs have a long-established and vital role to play in improving 
bladder storage function after SCI(72)Oral therapy is generally used as initial 
treatment for the patient who is incontinent while on ICC as a result of 
neurogenic detrusor over hyperactivity. Nevertheless, when oral treatment does 
not prove helpful, a tryout of intravesical oxybutynin can be carried out as this 
may offer advantage in some cases(68,69) Intravesical botulinum injections have 
been tried in numerous case series and the efficacy of the drug and reports which 
are now emerging suggest that a long-term program of regular re-injections is an 
acceptable option for some SCI patients who are eager to avoid major surgical 
measures (74,75) 
Augmentation cystoplasty (ileo-cystoplasty) has become well-known as a key tool 
in patients with compromised urine storage due to reduced bladder compliance or 
inflexible detrusor hyperactivity(76)This method is certainly effective in fabricating 
a big-capacity, low pressure storage reservoir but does require a significant surgical 
intervention with associated immediate and long-term risks. 
Division of the dorsal roots of S2, 3, 4 can effectively abolish reflex detrusor 
contractions. Usually this procedure is  accompanied by Brindley sacral root 
stimulator implantation .But it has been shown that a sacral bladder deafferentation 
can be effectively used in isolation in concurrence with ICC(77). As autonomic 
dysreflexia(AD) can be precipitated by a ano-rectal stimulus or lower urinary tract 
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problems, sacral bladder deafferentation  can be an important tool in the 
management of AD. 
A great number of surgical options exist for SCI patients with stress incontinence 
who desire to use ICC.  Rectus sheath fascial sling or the artificial urinary sphincter 
is good options for the SCI woman with stress incontinence. In  men the artificial 
sphincter has been widely used in such situation(78). Surgical closure of urethra 
may be required when the urethra is rigorously damaged mostly due to catheter. In 
women Raz illustrated the technique which does not need an abdominal 
incision(79) and In men, technique involve closure of the bulbar urethra rather than 
the bladder neck. 
A continent catheterizable abdominal channel is an added development that is 
relevant to the SCI population. The Mitrofanoff method is used most commonly for 
the abdominal conduit. In this the appendix is the conduit of choice(68). Another 
technique described by Monti suggest a short piece of small intestine can be 
reconstructed into a narrow , if the appendix is not available(80) .The creation of a 
catheterizable conduit can be carried out in concurrence with other methods like an 
augmentation cystoplasty to make safe storage capacity or surgery to correct stress 
incontinence. Also, it can be done in separation if the lower urinary tract is 
competent to provide safe and trustworthy urine storage without additional surgical 
intervention. 
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The benefits of an IC program include improved self-esteem and beneficialness to 
sexual activity, and it may result in a decreased incidence of bladder stones, UTIs, 
and bladder cancer. IC is generally accepted to be the best and safest long-term 
bladder management method(4). 
The most common problems with self-catheterization are symptomatic bacteriuria, 
urethral trauma, and incontinence. Occasionally a bladder stone formed on a nidus 
of hair or lint is found, and patients should be warned to avoid introducing foreign 
material into the bladder with the catheter. Urethral trauma and catheterization 
difficulties are usually caused by sphincter spasm. This can be managed by using 
extra lubrication and local anesthetic urethral gel (lidocaine 2%).  
 
COMPLICATIONS OF THE NEUROGENIC BLADDER 
Neurogenic bladder related complications used to be the primary cause for 
morbidity and mortality following spinal cord injury till the mid-20th century. 
There have been several high profile individuals who have succumbed to such 
complications. With the advent of better management techniques, currently 
neurogenic bladder is not the dreaded condition it used to be, though there still are 
significant complications associated with neurogenic bladder.(44) 
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Urinary tract infections  
Urinary tract infection (UTI) is the infection that affects part of the urinary tract. 
The infection of the lower urinary tract is called simple cystitis (bladder infection) 
and when it occurs in the upper urinary tract it is pyelonephritis (kidney infection). 
Symptoms from the lower urinary tract include painful urination and either frequent 
urination or urge to urinate (or both), while those of pyelonephritis include fever 
and flank pain in addition to the symptoms of lower UTI. In the elderly and the 
very young, symptoms may be vague or non-specific (81). The most common 
complication of indwelling catheter is infection. Urinary tract infections account for 
about 35% of hospital-acquired (nosocomial) infections and about 80%of these are 
associated with urinary catheters.(82,83) 
 
E.coli is the commonest organism found causing urinary tract infections in spinal 
cord injury patient on long term catheterisation. Other usual bacterial pathogens 
contributing to UTI include Klebsiella, Enterococci, pseudomonas, Proteus. Rarely 
they may be due to viral or fungal infections.(84,85) 
 
The clinical need for continuing catheterisation should be reviewed daily and the 
catheter removed as soon as possible. Long-term catheterisation is defined as a 
catheter in situ for greater than 14 days.(86) There is no consensus on how 
frequently such catheters should be changed. 
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O’Hagan (1996) defines intermittent catheterisation as “the episodic introduction of 
a catheter into the bladder to drain any residual urine, and then the removal of the 
catheter leaving the patient catheter free between catheterisations”.(63) Maynard 
and Glass reported that 80% of patients on clean IC monitored for 60 months 
continued this technique, suggesting low morbidity and high patient 
acceptance.(87) 
 
All patients with a neurogenic bladder are at a risk of urinary tract infections. Poor 
bladder emptying and high post void residual volume are known risk factors. 
Bladder emptying by Valsalva maneuver or by a Crede maneuver can lead to other 
complications such as epididymo-orchitis. Symptomatic infection is less common 
than asymptomatic catheter-associated bacteriuria. Seminal vesiculitis, prostatitis, 
epididymitis, and orchitis may be seen in patients with long-term urethral 
catheterization with blockage of the ejaculatory and prostatic ducts. There is a lack 
of evidence to state that among those on intermittent catheterization, incidence of 
urinary tract infections is affected by use of sterile or clean technique, coated or 
uncoated catheters, single (sterile) or multiple use (clean) catheters, self-
catheterization or catheterization by others, or by any other strategy. It is not 
possible to state that one catheter type, technique or strategy is better than another 
(88)The prevalence of urethral strictures and false passages increases with longer 
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use of intermittent catheterization. The most important preventive measures are 
good education of all involved in intermittent catheterization, good compliance, the 
use of a proper material and the application of a good catheterization technique.(89) 
 
Vesicoureteric reflux  
Vesicoureteric reflux is the condition in which there is reflux of urine from the 
bladder into the ureters. It is diagnosed by cystogram or videourodynamics. 
Vesicoureteric reflux in individuals with neurogenic bladder is a potential indicator 
of failure to maintain optimal bladder pressure volume profile. In spinal cord 
injured patients, reflux is seen in 17-25% of people with suprasacral injuries. 
Reflux may occur with all forms of bladder management, particularly with the use 
of an indwelling catheter. If  bladder pressure can be lowered and maintained, it is 
rare that vesicoureteric reflux persists. Persistent reflux increases the risk of upper 
tract infection, may predispose to calculi formation, and lead to renal deterioration 
and even death from renal disease in patients with spinal cord injury.(90) 
 
Hydronephrosis  
Hydroureteronephrosis  may lead to renal deterioration, renal failure, and death. A 
high-pressure, poorly compliant bladder causes upper tract dilatation with or 
without vesicoureteric reflux. McGuire and colleagues first demonstrated the effect 
of elevated bladder pressure in patients with spina bifida when he noted that in 
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patients with elevated bladder leak point pressures (>40 cm H20) there was a 68% 
incidence of vesicoureteral reflux and an 81% incidence of hydronephrosis(6). 
When reflux is found in patients with neurogenic disease, it contributes further to 
the development of hydronephrosis. Hydronephrosis may also be caused by 
detrusor sphincter dyssynergia and calculus disease, and other causes which could 
obstruct one or both ureters or the urethra. Hydronephrosis is usually diagnosed by 
ultrasonography, CT or MRI scans. Hydronephrosis is classified as mild, moderate 
or severe based on the observed size of the renal calyces and renal pelvis.  
Stones  
Loss of calcium from the bones occurs following spinal cord injury. Renal stone 
incidence is mainly due to hypercalciuria. Over the next 10 years upper tract stones 
are found in 8%, with many of these secondary to infection. The incidence of 
bladder stones in the first 9 months in patients on intermittent catheterization is 
2.3%. In the presence of an indwelling catheter, the prevalence is much higher (25) 
 
Antibiotic management of UTI  in patient with Intermittent bladder 
catheterization  
 
The periurethral area of the subjects using ICC is colonized with enteric organisms 
supposed to have derived from the gastrointestinal tract. ICC facilitates the 
inoculation of periurethral bacteria into the bladder and hence bacteriuria is very 
common (14,16). On  the contrary, ICC reduces the possibility of infections (14) by  
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making a chronically infected bladder sterile. Antibiotic misuse and the 
development of resistant organisms are of major issue all over the medical world. 
Over usage of antimicrobials can result in rapidly adapting DNA sequences(91).  
 
A randomized control study of bacteriuria control during early intermittent bladder 
catheterization was carried out by Anderson etal in 1980 on acute spinal cord injury 
patients. One group received nitrofurantoin and other group received no antibiotics. 
Duration of study was till a balanced bladder was attained or till discharge. The 
outcome measure was rate of bacteruria. They did not evaluate symptomatic UTI in 
this study. The study showed significant reduction in infection rates when oral and 
intravesical antibiotics were used.(92). 
 
In 1982 Duffy et al did a cross over study in neurogenic bladder patients. 
Nitrofurantoin was given in one group and placebo in the other group for 3 months. 
Then this was crossed over for another 3 months. This study also set as outcome the 
rate of bacteruria, both asymptomatic and symptomatic per catheterization week. 
The study showed prophylactic antibiotic group 
had a lower rateof bacteruria  than patients not receiving prophylactic antibiotics, 
but this was not statistically significant.(93) 
Mohler et al in 1987 did a randomized control study of  UTI during early 
intermittent bladder catheterization with TMP-SMX. . Suppression with daily single 
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dose 160 mg. trimethoprim and 800 mg. sulfamethoxazole compared to placebo 
showed no difference in the rate of symptomatic or total urinary tract infections.  
(94). 
 
Gribble et al, in 1993 conducted a study to establish the effectiveness of low dose 
of trimethoprim-sulfamethoxazole (TMP-SMX) for prophylaxis of urinary tract 
infection during the first 16 weeks of ICC in persons with recent spinal cord injury. 
TMP-SMX significantly reduces bacteriuria and symptomatic urinary tract 
infection. Nevertheless, adverse reactions related to TMP-SMX were common in 
the study group who received antibiotic. Also there was increased colonization and 
frequent burst through bacteriuria with TMP-SMX-resistant organisms. 
 
In 1994, Johnson et al conducted a double-blinded, placebo-controlled cross-over 
study in children with neurogenic bladder due to myelomeningocele.  
Nitrofurantoin was given in one group and placebo in the other group for 12 weeks. 
Then this was crossed over for another 12 weeks. Study showed fewer UTIs in the 
control group which can be due to carry over effect of Nitrofurantoin to the control 
group(95) 
 
Schlager et al did a study in 1998 to find out the outcome of Nitrofurantoin 
prophylaxis on rates of bacteriuria and symptomatic urinary tract infection in 
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children with chronic neurogenic bladder performing ICC. This was double blind, 
placebo controlled, cross over study with total duration of 11 months with 1 month 
washout period. It calculated the symptomatic UTI per catheterization week. In the  
Nitrofurantoin group, the frequency of bacteriuria was high. Escherichia coli was 
the most common pathogen isolated during administration of placebo. This was 
replaced by resistant Klebsiella and Pseudomonas during the Nitrofurantoin 
therapy. Symptomatic infection dropped to half on Nitrofurantoin, but this decline 
was due solely to infections caused by E. coli. Despite an increased frequency of 
resistant organisms on Nitrofurantoin prophylaxis, an increase in urinary tract 
infections caused by these resistant organisms did not occur. Study showed half risk 
of symptomatic UTI in prophylactic group with no statistical significance.(96) 
A low dose antibiotic prophylaxis was used in case of patients with spinal bifida on 
ICC. In 2011 Zegers et al did a randomized controlled trial to detect the 
effectiveness of long term Nitrofurantoin prophylaxis in ICC patients. A total of 
176 subjects with spina bifida were recruited One group continued low dose 
antibiotic, while the other group discontinued it. 
 
The study continued for 18 months. The antibiotic prophylaxis group had 
significantly fewer afebrile symptomatic UTI with number needed to treat for an 
additional harmful outcome of 2.2. Thus this study suggested there is no need of 
long term prophylaxis antibiotic treatment in ICC patients.(97) 
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Another Cochrane review on urinary catheter policies on short term bladder 
drainage compared Bacteriuria, both asymptomatic and symptomatic between 
Indwelling urethral catheterisation and intermittent catheterisation. The limited data 
presented suggested that ICC reduced the risk of bacteriuria when matched up with 
indwelling urethral catheterisation 
 
A Cochrane review on Urinary catheter policies for long-term bladder management 
compared between antibiotic prophylaxis and giving antibiotics when clinically 
indicated. For patients using ICC, the data were inconclusive. Only one out of the 
three studies favoured antibiotic prophylaxis with statistically significant 
differences. The data available is not enough as a foundation for determining 
practice. In the current study, we aim to study the role of antibiotics during the 
initiation of self intermittent clean catheterisation in long term catheterised spinal 
cord injury patients. 
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Subjects &Methods 
Setting 
Christian Medical College hospital (CMCH) is a tertiary care hospital situated 
in Vellore, Tamil Nadu, India, with an inpatient capacity of approximately 
2500 beds, and average outpatient attendance of about 5000 persons per day. 
The Department of Physical Medicine & Rehabilitation in CMCH has an 
inpatient capacity of about 115 beds, and the average outpatient attendance is 
about 100 persons per day. Every year, about 300 persons, predominantly from 
Tamil Nadu, Andhra Pradesh, Kerala, West Bengal, Bihar and Jharkhand, are 
referred here for SCI rehabilitation, which includes in-house neuro urological 
evaluation and intervention. Usually intermittent clean catheterisation is started 
for bladder management in paraplegics and occasionally in tetraplegics with 
good hand function.  
 
The study 
 
The study was approved by the Institutional Review Board of the Christian 
Medical College. 
 32 consecutive individuals undergoing in-patient rehabilitation following SCI 
at the Department of Physical Medicine & Rehabilitation, CMCH, were 
recruited for the study after obtaining informed consent. 
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Type of study:  Randomized Control Trial. 
Subjects: Patients with spinal cord injury on indwelling urethral catheter 
Inclusion Criteria: 
 Spinal cord Injury patients on indwelling urethral catheter with ≤ 3 
microorganisms sensitive to 1
st
/2
nd 
generation oral/parenteral antibiotics 
 Age 18 to 60 years 
 Adequate cognition and communication abilities 
Exclusion Criteria: 
 Any congenital or acquired pathology in the Upper renal tract. 
 Congenital or acquired urethral anatomy such as stricture, false passages and 
bladder neck obstruction. 
 Inability or unwillingness to adhere to the catheterization time schedule or the 
fluid intake regimen 
 Patients with pan resistant cultures/ cultures with organisms sensitive only to 
expensive  parentral antibiotics 
 Tendency to develop autonomic dysreflexia with bladder filling despite 
treatment 
 Any  infections at the time of recruitment 
 Participating in any other studies 
 Patients with psychiatric problems 
 
Target sample size and rationale 
Sample size is calculated as per Cochrane review on urinary catheter policies 
for long term bladder drainage (Gribble 1993). 
Sample size was calculated as follows 
1. Proportion of expected symptomatic UTI in Antibiotic group: 6% 
2. Proportion of expected symptomatic UTI in control group: 30% 
3. Power of study: 80% 
4. Significance level: 5% 
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Sample size=50(25 in each group) 
Due to inadequacy of time, calculated sample size was not attained. Hence this 
study was done as an interim study study with 32 patients, 16 in the 
experimental group and 16 in the control.  
Method of randomization: Randomized codes generated by computer based 
programme. 
Blinding and masking: Blinding not possible as the mode of administration of 
medications used in the intervention group will vary in different subjects 
according to the urine culture.  
 Methodology: 
 Patients with spinal cord injury  admitted in the department of PMR underwent  
routine investigations including urine microscopy & culture & sensitivity, 
ultrasound abdomen,  X ray  KUB and urine dip stick test.They were screened 
for upper & lower renal tracts pathology including hydronephrosis, renal & 
bladder calculi and cystitis changes. Patients were then recruited into the study 
according to the inclusion & exclusion criteria and an informed consent was 
obtained. 
 Once included in the study, they were randomized into 2 groups –the 
intervention group and the control group. The intervention group was started on 
self-intermittent clean catheterization under the cover of  culture specific  
1
st
/2
nd 
generation oral/parenteral   antibiotics for 5 days. If the urine culture and 
sensitivity had shown no growth they were given oral Quinolones for 5 days. 
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The control group did not receive any antibiotic cover while being initiated on 
intermittent catheterization. Both the groups were observed for symptomatic 
UTI as per modified CDC (Centers for Disease Control) criteria (Table no.5 ) 
for a period of   one week. The CDC criterion for symptomatic UTI was 
modified to include cultures with ≤ 3 microorganisms. This was because Urine 
culture and sensitivity done in the Microbiology laboratory, Christian Medical 
College, Vellore reported up to a maximum of 3 organisms as spinal cord 
injury patients on indwelling catheter usually shows a polymicrobial culture. 
Dipstick test was done using Siemens-CLINITEK Status + Analyzer and the 
Multistix
®
 10 SG reagent strip. 
 
Primary Outcome: 
Symptomatic urinary tract infection as per modified CDC criteria (Table 5) 
 
Statistical Analysis: 
Comparisons were made between antibiotic and non-antibiotic groups wherever 
possible.  For comparisons we used Chi- Square test and Fisher’s Exact test. 
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Table 5- Modified CDC criteria for Symptomatic UTI 
 
 
1.A positive urine culture of ≥105 colony-forming units (CFU)/ml with no 
more than 3 microorganisms  
AND 
at least 1 of the following signs or symptoms with no other recognized 
cause:  
fever (>38°C), urgency, frequency, dysuria, suprapubic tenderness, or 
costovertebral angle pain or tenderness 
  
2. A positive urine culture of ≥103 and <105 CFU/ml with no more than 3  
microorganisms 
 
AND 
at least 1 of the following signs or symptoms with no other recognized 
cause:  
fever (>38°C), urgency, frequency, dysuria, suprapubic tenderness, or 
costovertebral angle pain or tenderness  
 
AND 
 
at least 1 of the following findings:  
a. positive dipstick for leukocyte esterase and/or nitrite  
b. pyuria (urine specimen with ≥10 white blood cells [WBC]/mm3 of 
unspun urine or ≥3 WBC/high power field of spun urine)  
c. microorganisms seen on Gram stain of unspun urine  
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Table 6- Flow chart of the study 
 
Flow chart for the study 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
          
                              
 
SCI Patients on indwelling urinary catheter 
Baseline investigations (urine routine ,cuture 
& sensitvity,USG & Xray KUB,urine dip stick 
test 
Inclusion criteria 
  Yes   No 
Excluded 
Randomisationn
n 
CBDICC 
Urine C/S 
Antibiotic(oral/iv) 
x  5days 
 
  No Antibiotic 
Observe for symptomatic 
UTI   for 1 week 
Symptomatic 
UTI  
point 
 
No symptomatic 
UTI 
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RESULTS AND ANALYSIS 
32 subjects with spinal cord injury on indwelling urethral catheter were enrolled and 
randomised into the intervention and control groups- 16 in the group which received 
antibiotics   and 16 in the group which did not receive antibiotics. Comparisons were 
made between antibiotic and non-antibiotic groups wherever possible.  For 
comparisons we used Chi- Square test, Fisher’s Exact test. There were no drop outs 
after recruitment. The study was conducted from May 2013 to October 2013. 
 
Baseline demographic and clinical characteristics of the participants 
Distribution according to Age in the study group 
Out of total 32 subjects, majority of the patients were in the age group between 20-29 
years (table 7).    
 
Table 7- Distribution according to Age 
Age group 
SCI 
No % 
<20 7 21.9% 
20-29 9 28.1% 
30-39 7 21.9% 
40-49 4 12.5 % 
50-59 5 15.6 % 
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Figure 3 -Distribution according to age
 
 
Age distribution between male and female subjects 
In the study group, mean age of males was 32.8 years and that of females was 26.6 
years(table 8)  
Table 8 
 Gender No. Mean(yrs) Std.Deviation 
AGE Male 27 32.8 13.4 
Female 5 26.6 9.04 
 
Distribution according to gender 
Of the total 32 subjects, 27 (84%) were males and 5 (16%) were females. Fisher's test 
showed no significant difference in the gender characteristics in the 2 study groups.  
 
<20 yr 
20-29 yrs 
30-39 yrs 
40-49 yrs 
50-59 yrs 
21.90% 
28.10% 
21.90% 
12.50% 
15.60% 
Distribution according to age 
Distribution according to age 
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Comparison of gender characteristics of the study group is given in Table.8. 
Table 8-Distribution according to gender 
Gender Antibiotic Non  antibiotic significance 
No. Percentage No. Percentage 
Male 14 87.5% 13 81.3% 1.000 
Female 2 12.5% 3 18.8% 
 
Comparison of gender characteristics of the study groups is given in figure 4 
 
Figure 4- Distribution according to gender 
 
 
Distribution according to level of spinal cord injury 
Among the total 32 subjects, 31 (96.9%) were paraplegics and 1 (3.1%) was tetraplegic. In 
the antibiotic group all 16 subjects were paraplegics and in the non-antibiotic group, 15 
subjects were paraplegics and 1 subject was tetraplegic.       
Antibiotic gp Non antibiotic gp 
87.50% 
81.30% 
12.50% 
18.80% 
Male 
Female 
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Table 9- Distribution according to level of spinal cord injury 
 Antibiotic Non  antibiotic Total 
No. Percentage No. Percentage No. Percentage 
Paraplegics 16 100% 15 93.5% 31 96.9% 
Tetraplegics 0 0% 1 6.5% 1 3.1% 
 
Figure 5 Distribution according to level of SCI 
 
 
Distribution according to the duration of Spinal Cord Injury 
56.3% of the study group had duration of spinal cord injury less than 3 months when clean 
self-intermittent catheterization was started. Almost 81% of the patients were started on 
intermittent clean catheterization within a period of 1 year of injury.  
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Table 10-Comparison according to duration  of spinal cord injury 
 
Duration of SCI Number of persons % of persons 
0-3months 18 56.3% 
3- 6 months 4 12.5% 
6-12 months 4 12.5% 
1-5 years 5 15.6% 
>5 year 1 3.1% 
Total 32 100% 
 
Figure 6-Distribution according to the duration of Spinal Cord Injury 
 
 
 
 
0-3m 3-6m 6-12m 1-5yr >5yr 
56.30% 
12.50% 12.50% 
15.60% 
3.10% 
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Distribution according to the etiology of Spinal Cord Injury 
 
Among the 32 subjects, etiology of SCI varied. In 28 subjects, trauma was the major 
cause contributing to 87.5%. The most common type of trauma was fall from height (19 
subjects, 67.9%) followed by road traffic accident (7 subjects, 25%) and fall of weight on 
back (2 subjects, 7.0%). Non traumatic causes included 2 cases of transverse myelitis, 1 
case each of Pott’s spine and Intervertebral disc prolapse. 
 
Table 11- Distribution according to the etiology of SCI 
 
Cause of SCI Number of subjects Percentage 
FFH 19 59.4% 
RTA 7 21.9% 
WOB 2 6.3% 
TM 2 6.3% 
TBS 1 3.1% 
IDP 1 3.1% 
Total 32 100% 
 
 
 
FFH   = Fall from height  
RTA   = Road traffic accident  
WOB  = Fall of weight over the back 
TM     =Transverse myelitis 
TBS    =Tuberculosis of spine 
IDP     =Intervertebral disc prolapse 
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Figure 7- Distribution according to the etiology of SCI 
 
 
Distribution according to the mode of management 
 
Out of total 32 subjects, 28 underwent surgical fixation of spine. The 5 subjects who 
underwent conservative management included 2 cases of transverse myelitis, 1 case of 
Potts spine and 2 cases of traumatic spinal cord injury. (Table-12) 
Table 12- Distribution according to the mode of management 
 
Management Number Percentage 
Surgery 28 87.5% 
Conservative 5 12.5% 
Total 32 100% 
 
  
60% 22% 
6% 
6% 
3% 3% 
FFH RTA WOB TM TBS IDP 
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Distribution of no. of types of organisms in the urine culture in both groups at the 
initiation of study 
Among 32 subjects, 14 urine cultures were monomicrobial and 18 urine cultures were 
polymicrobial.  
 
Table 13- Distribution of no. of types of organisms in the urine culture in both groups at 
the initiation of study 
 
No. of 
types  of 
microbes 
Antibiotic Non  Antibiotic Significance 
No. Percentage  No. Percentage 
                 
1 
9 56.3% 5 31.3% 0.284 
                
2 
5 31.3% 6 37.5% 
                
3 
2 12.5% 5 31.3% 
 
 
 
Distribution according to the type of microbe in urine before initiation of 
ICC 
Of the total 32 urine cultures done, the most common organism isolated was 
Escherichia coli. E.coli was present in 23 urine cultures which accounted to 
72%. This was followed by Klebsiella- 8(25%), Enterococcus- 8(25%), 
Pseudomonas- 7(22%), Proteus-2(6%), Citrobacter- 2(6%). 
 
Comparison of different species of microbes is  given in Table- 14 & Figure-8. 
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Table 14-No. of cultures growing each microbe 
Organism Number 
E.coli  
 
23 
Klebsiella 8 
Enterococcus 8 
Pseudomonas 7 
Proteus 2 
Citrobacter 2 
Others  4 
 
Figure 8 No. of cultures growing different species of microbes 
 
E.coli , 23 
Klebsiella, 8 
Entero, 8 
Pseudomonas, 7 
Proteus, 2 
Citrobacter, 2 
Others , 4 
0 5 10 15 20 25 number 
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Distribution according to the ESBL organism in urine before initiation of ICC 
In the total 32 urine cultures, Extended spectrum beta lactamase (ESBL) producing 
E.coli was seen in  17 and Klebsiella was seen in 6.(Table 15, Figure 9). One species 
of Klebsiella was carbapenem resistant. Another urine sample contained 2 species of 
 E.coli 1 and E.coli 2. 
Table 15-Distribution of ESBL organisms 
Organism ESBL + ESBL - % of ESBL + 
E.coli 17 8 74% 
Klebsiella 6 3 66.7% 
 
Figure 9-Distribution of ESBL organisms 
 
 
E.Coli Klebsiella 
17 
6 
8 
3 
ESBL + ESBL - 
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Distribution according to the organism count in urine before initiation of 
ICC 
Out of total 32 subjects, 14 subjects in each group had bacterial colony forming 
units count more than ≥10
5
/  ml and 2 subjects in each group had CFU counts 
between 103  and  <105/  ml.  
 Fisher's test done showed no significant difference in the CFU counts between 
the 2 study groups. Comparison of CFU counts between the 2 study groups is 
given in Table 16 & Figure 10 
Table 16                               CFUC- colony-forming units / ml 
CFU COUNT ANTIBIOTIC NON  ANTIBIOTIC Significance  
No. % No. % 
 ≥10
5
/ ml
 14 87.5% 14 87.5% 1.000 
 ≥103 to <105/ ml 2 12.5% 2 12.5% 
 
Figure 10 Distribution according to the organism count in urine before 
initiation of ICC 
 
Antibiotic Non Antibiotic 
12.50% 12.50% 
87.50% 87.50% 
 CFU Count ≥103 to <105/ ml 
 CFU Count ≥105/ ml 
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Distribution according to the dipstick test in both groups before initiation 
of ICC 
Dipstick test values were obtained for 18 subjects. 17 subjects had a positive 
dipstick test. Fisher's test done show no significant difference in the dipstick 
result between the 2 study groups(table 17). 
Table 17  
Urine dip stick Antibiotic Non  Antibiotic Significance 
No. Percentage  No. Percentage 
Positive  8 100% 9 90% 1.000 
Negative 
 
0 0% 1 10% 
 
Distribution according to the Gram stain in urine in study group before 
initiation of ICC 
Gram stains were obtained for 18 subjects. 14 subjects had a positive Gram 
stain test.  Fisher's test done show no significant difference in the Gram stain 
result between the 2 study groups. (Table 18) 
Table 18 
 
Gram 
stain 
Antibiotic Group 
 
Non  Antibiotic Group Significance 
No. % No. % 
Positive
 
8 88.9% 6 66.7% 0.576 
Negative 
 
1 11.1% 3 33.3% 
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Figure 11 
 
Figure 12 
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Figure 13 
 
Distribution according to the occurrence of symptomatic UTI in both 
groups at the end of the study 
Of the total 32 subjects, both antibiotic and non-antibiotic groups had 1 case 
each of symptomatic UTI within 1 week. Remaining 30 subjects did not 
develop symptomatic UTI. Fisher's test done showed no significant difference 
in the occurrence of symptomatic UTI between the 2 study groups as shown in 
table 19 and figure 12. 
Table 19 
SYMP 
UTI 
Antibiotic group Non Antibiotic 
group 
Significance 
No. Percentage No. Percentage 
Present 
 
1 6.25% 1 6.25%  
 
1.000 Absent 
 
15 93.75% 15 93.75% 
Total 16 100% 16 100% 
94.40% 
77.80% 
5.60% 
22.20% 
Dipstick 
Gstain 
Negative Positive 
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Figure 14                         SYMP UTI= Symptomatic UTI 
 
 
 
Though criteria for symptomatic UTI included symptoms like urgency, 
frequency, dysuria, suprapubic tenderness, or costovertebral angle pain or 
tenderness, these symptoms were not appreciated in this group of spinal cord 
injured subjects. Hence a significant (≥105 colony-forming units CFU count) 
bacteriruria with fever (>38°C/100.4°F) or bacteruria with CFU count (≥103 and 
<10
5
 CFU/ml) with fever (>38°C/100.4°F) and positive gram stain/positive 
dipstick stick/pyuria was considered as symptomatic UTI. 
 
In this study, 2 subjects (one from each group) developed symptomatic UTI. 
The subject who developed symptomatic UTI in the non-antibiotic group had a 
significant bacteriruria (≥105 colony-forming units CFU count) before and after 
the study. He also had a positive gram stain and dipstick test which did not 
change at the end of the study. He was febrile on the 4
th
 day of study. The other 
Antibiotic Non Antibiotic 
6.25% 6.25% 
93.75% 93.75% 
sympUTI present 
sympUTI absent  
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subject who developed symptomatic UTI was in the antibiotic group. He had a 
probably significant bacteriruria (≥103 and <105 CFU/ml). He also had a 
positive dipstick stick and negative gram stain which did not change at the end 
of the study. He was febrile on the 2
nd
   day of study. 
 
Antibiotics used in the study 
Of the32 subjects, 16 were in the antibiotic group. 9 subjects received 
Nitrofurantoin tablets alone, 4 received Nitrofurantoin with an additional 
antibiotic, 1 received oral Cotrimoxazole. Only 2 subjects received parenteral 
antibiotics as culture was resistant to oral medications. (Table18) 
Table 20-Antibiotics in the intervention group 
Antibiotic  Route  No. of subjects 
Nitrofurantoin Oral  9 
Nitrofurantoin & Levofloxacin Oral 2 
Nitrofurantoin & Co-amoxiclav Oral 1 
Nitrofurantoin & Co-Trimoxazole Oral 1 
Co-Trimoxazole Oral 1 
Amikacin Intravenous  2 
Total  16 
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DISCUSSION 
 
The technique of   ICC was reintroduced by Lapides in 1972. This transformed 
the management of neuropathic bladder(14,15). In this study we aimed to study 
the need for antibiotic cover during the initiation of ICC in spinal cord injury 
patients. 
In this study, the majority of subjects was in the age range 20-29 years. This 
was similar to the incidence worldwide which show that young adults are more 
prone for  spinal cord injury(98). 
Most of the subjects were males in both groups. Literature shows an average of 
2.5 to 3.5 male /female ratio. In the current study this ratio was 5.4 : 1(98,99).  
The commonest cause of spinal cord injury was trauma. Current study showed 
fall from height as the commonest cause of trauma. In most of the studies road 
traffic or motor vehicle accident ranks first as the cause of trauma(98) followed 
by fall.  Surgical stabilization was done in 93.1 % which was comparatively 
more compared to other studies(100). 
56.3% of the study group had duration of spinal cord injury less than 3 months 
when clean self-intermittent catheterization was started. Almost 81% of the 
patients were started on intermittent clean catheterization within a period of 1 
year of injury. Early initiation of ICC has been shown to reduce risk of bladder 
complications. 
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Studies show that among long-term catheterized patients, infections are mostly 
polymicrobial in up to 95% of urine specimens(101). In the current study 
percentage of polymicrobial infection was about 78.1%. This mild reduction in 
the percentage could be due to non-inclusion of subjects with polymicrobial 
infections with pan resistant urine culture & sensitivity and urine culture with 
organisms sensitive only to costly parenteral antibiotics.  
When a patient is catheterised, the risk of acquiring bacteriuria has been 
estimated as 5% for each day of catheterisation, accumulating to 100% in 4 
weeks. The longer the catheter remains in situ, the higher the risk of infection
. 
Among long-term catheterized patients infections are mostly polymicrobial in 
up to 95% of urine specimens. Such specimens commonly have 3-4 bacterial 
species, each at concentrations of 10
5 
CFU/ml or more(101). In the current 
study, 87.5% of the subjects had colony forming unit counts ≥ 105 CFU/ml. 
Both the study groups had uniform distribution of colony counts in the urine. 
Literature shows that ESBL was detected in 6% of isolates, the majority of 
which were E. coli (83%) followed by Klebsiella and was more isolated from 
urine. (102) In another study E. coli isolates showed ESBL production in 40.4 
% whereas for Klebsiella, ESBL production was found in 44.9 %. (103) 
Prevalence was more among Klebsiella in certain other studies. (104,105) 
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In this study the percentage of ESBL was more among E.coli than Klebsiella. 
(Table 16) 
In this study, the main question was to assess the need for antibiotics during the 
initiation of intermittent clean catheterisation. Symptomatic urinary tract 
infection was the outcome measured.  
 
 The CDC (Centers for Disease Control and Prevention) criterion was used with 
some modification for assessing for symptomatic UTI. According to the CDC 
criteria (Table 4) “A positive urine culture of ≥105 colony-forming units 
(CFU)/ml with no more than 2 species of microorganisms” is considered as one 
of the criteria for diagnosing symptomatic UTI. But in this study as most of the 
subjects had more than 3 species in the urine culture, the criterion was modified 
to include cultures with ≤ 3 species. This is a common observation in spinal 
cord injury patients on long term indwelling urinary catheter. 
 
Of the total 32 subjects, both antibiotic and non-antibiotic groups had 1 case 
each of symptomatic UTI.  There was no significant difference in the incidence 
of symptomatic UTI in the 2 groups. 
There is well documented literature regarding the ineffectiveness of antibiotic 
prophylaxis during the continuation of ICC. These studies suggest avoidance of 
prophylactic antibiotics to prevent multi resistant organisms.(106) In fact some 
studies pointed out increased incidence of symptomatic UTI in patients using 
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regular prophylactic antibiotics during ICC because of the development of 
resistant strains.(107) 
 
 There are many such studies related to antibiotic prophylaxis in patients with 
spinal cord injury on long term indwelling urethral catheterisation and those on 
ICC. But there are no specific studies regarding the role of antibiotics during 
the initiation of ICC in long term catheterised patients with spinal cord injury. 
During the initiation of ICC on a long term catheterised patient, there is 
increased chance of retention of urine in the bladder. Urinary retention in turn 
causing bladder distension is considered as risk factor for UTI(14,15). 
Moreover the periurethral area of the subjects using ICC is colonized with 
enteric organisms supposed to have derived from the gastrointestinal tract. ICC 
facilitates the inoculation of periurethral bacteria into the bladder and hence 
bacteriuria is very common (14,16). Also the patient who is new to the 
procedure has chances of lack of proper clean technique during the ICC. Hence 
there is a likely chance for increased symptomatic UTI during the first week of 
initiation of ICC. 
 
According to our previous clinical experience the protocol was treatment with 
urine culture specific 1
st
/2
nd 
Antibiotics (oral/parenteral) while initiating ICC in 
long term catheterised spinal cord injury patients. More expensive 2
nd
 line 
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antibiotics are not generally used. Still the expense of the treatment usually   
ranges from  200-1500.  
 
Two trials reported data on symptomatic bacteriuria in patients with neurogenic 
bladder. The first study on the effectiveness of low dose of trimethoprim-
sulfamethoxazole (TMP-SMX) for prophylaxis of urinary tract infection 
showed significant reduction in bacteriuria and symptomatic urinary tract 
infection. Nevertheless, adverse reactions related to the drug, increased 
colonization and frequent burst through bacteriuria with TMP-SMX-resistant 
organisms were observed in this study. Fewer patients in the prophylactic 
antibiotic group had at least one episode of symptomatic bacteriuria, and this 
was statistically significant.(108). 
 
In the other trial, trimethoprim-sulfamethoxazole (TMP-SMX 160/800 mg) & 
placebo was tried in patients on ICC. The results showed that patients in the 
prophylactic antibiotic group had a lower rate of symptomatic UTI than patients 
not receiving prophylactic antibiotics but this was not statistically significant 
(98) 
 
A Cochrane review on urinary catheter policies for long-term bladder 
management compared between antibiotic prophylaxis and giving antibiotics 
when microbiologically indicated. For patients using ICC, the data was 
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inconclusive. Only one out of the three studies favoured antibiotic prophylaxis 
with statistically significant differences. The data available is not enough as a 
foundation for determining practice. 
 
In the current study we assessed the patient, for symptomatic UTI for a period 
of 1 week after starting the ICC. There was no significant difference in the 
occurrence of symptomatic UTI in both the study groups. This points out that 
the use of antibiotics during the initiation of ICC may not be essential. If so this 
observation will be useful in the development of protocols for the management 
of neurogenic bladder. Initiation of ICC without antibiotic may be useful to 
prevent multi drug resistance and reduce the economic burden on patients by 
avoiding the expensive antibiotics. 
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CONCLUSION 
 
There was no statistically significant difference in the incidence of symptomatic 
urinary tract infection in the antibiotic and non-antibiotic groups after the 
initiation of ICC. Symptomatic UTI was defined on the basis of CDC criteria. 
Hence the study suggests that it may not be necessary to use antibiotic cover 
during initiation of intermittent clean catheterisation in spinal cord injury 
patients. However the study was limited by a small sample size and short 
duration of follow up. 
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Limitations of the study 
The study had some limitations: 
1. The sample size was small due to inadequacy of time. Hence this was 
done as an interim study.  
2. There was no blinding in this study. This was because intervention group 
received oral or parenteral antibiotics according to the urine culture and 
sensitivity and hence blinding was not possible.  
3. As significant number of the urine cultures showed more than 3 
organisms, modification of CDC Criteria for symptomatic UTI was 
adopted. 
4. Patients with panresistant organisms in urine cultures/ organisms 
sensitive only to costly parentral antibiotics were excluded as this was the 
standard protocol being followed in our department. 
 
Recommendations for future studies: 
Future studies with a larger sample size may be useful as the current study had 
a smaller study group. Urodynamic studies to characterise the type of bladder as 
hyper reflexic or areflexic and correlating this data with the incidence of 
symptomatic UTI in the two groups will also yield useful information.  
 
 
96 
 
Bibliography 
1.  Moslavac S, Dzidic I, Kejla Z. Neurogenic detrusor overactivity: Comparison 
between complete and incomplete spinal cord injury patients. Neurourol 
Urodyn. 2008;27(6):504–6.  
2.  Erol B, Koçak T, Kadioğlu A, Müslümanoğlu L, Karamehmetoğlu S, Akinci 
M, et al. [The relationship between level of injury and bladder behavior in 
patients with post-traumatic spinal cord injury]. Ulus Travma Ve Acil Cerrahi 
Derg Turk J Trauma Emerg Surg TJTES. 2009 Jul;15(4):377–82.  
3.  Ku JH. The management of neurogenic bladder and quality of life in spinal 
cord injury. BJU Int. 2006;98(4):739–45.  
4.  Steven Kirshblum, Monifa Brooks. DeLisa’s Physical Medicine and 
Rehabilitation: Principles and Practice, Two Volume Set. Rehabilitation of 
Spinal Cord Injury. 5th ed. p. 665–716.  
5.  Krause JS, Carter RE, Pickelsimer EE, Wilson D. A prospective study of 
health and risk of mortality after spinal cord injury. Arch Phys Med Rehabil. 
2008 Aug;89(8):1482–91.  
6.  Le CT, Price M. Survival from spinal cord injury. J Chronic Dis. 
1982;35(6):487–92.  
7.  Niël-Weise BS, van den Broek PJ. Urinary catheter policies for long-term 
bladder drainage. Cochrane Database Syst Rev. 2005;(1):CD004201.  
8.  Sandock DS, Gothe BG, Bodner DR. Trimethoprim-sulfamethoxazole 
prophylaxis against urinary tract infection in the chronic spinal cord injury 
patient. Paraplegia. 1995 Mar;33(3):156–60.  
9.  Stickler DJ, Chawla JC. An appraisal of antibiotic policies for urinary tract 
infections in patients with spinal cord injuries undergoing long-term 
intermittent catheterisation. Spinal Cord. 1988 Aug;26(4):215–25.  
10.  Wazait HD, van der Meullen J, Patel HRH, Brown CT, Gadgil S, Miller 
RA, et al. Antibiotics on urethral catheter withdrawal: a hit and miss affair. J 
Hosp Infect. 2004 Dec;58(4):297–302.  
11.  Niël-Weise BS, van den Broek PJ. Antibiotic policies for short-term 
catheter bladder drainage in adults. Cochrane Database Syst Rev. 
2005;(3):CD005428.  
97 
 
12.  Jewes LA, Gillespie WA, Leadbetter A, Myers B, Simpson RA, Stower 
MJ, et al. Bacteriuria and bacteraemia in patients with long-term indwelling 
catheters-a domiciliary study. J Med Microbiol. 1988;26(1):61–5.  
13.  Olson ES, Cookson BD. Do antimicrobials have a role in preventing 
septicaemia following instrumentation of the urinary tract? J Hosp Infect. 
2000 Jun;45(2):85–97.  
14.  Lapides J, Diokno AC, Lowe BS, Kalish MD. Followup on unsterile 
intermittent self-catheterization. J Urol. 1974 Feb;111(2):184–7.  
15.  Lapides J, Diokno AC, Silber SJ, Lowe BS. Clean, intermittent self-
catheterization in the treatment of urinary tract disease. J Urol. 1972 
Mar;107(3):458–61.  
16.  Schlager TA, Anderson S, Trudell J, Hendley JO. Nitrofurantoin 
prophylaxis for bacteriuria and urinary tract infection in children with 
neurogenic bladder on intermittent catheterization. J Pediatr. 1998 
Apr;132(4):704–8.  
17.  Elsberg CA. The Edwin Smith Surgical Papyrus and the diagnosis and 
treatment of injuries of the skull and spine 5000 years ago.Ann Med 
Hist.1931;3:271.  
18.  Nobunaga AI, Go BK, Karunas RB. Recent demographic and injury trends 
in people served by the Model Spinal Cord Injury Care Systems. Arch Phys 
Med Rehabil. 1999 Nov;80(11):1372–82.  
19.  DeVivo MJ. Epidemiology of traumatic spinal cord injury: trends and 
future implications. Spinal Cord. 2012 May;50(5):365–72.  
20.  Thomas N. Bryce, Kristjan T. Ragnarsson, Adam B. Stein, Fin Biering-
Sorensen. Spinal cord injury. Physical Medicine and Rehabilitation Randall  
L Braddom. 4th ed. p. 1293–346.  
21.  Spinal Cord Injury Facts and Figures at a Glance. J Spinal Cord Med. 
2012 Jul;35(4):197–8.  
22.  DeVivo MJ, Krause JS, Lammertse DP. Recent trends in mortality and 
causes of death among persons with spinal cord injury. Arch Phys Med 
Rehabil. 1999 Nov;80(11):1411–9.  
23.  Jonathan Glass (Editor, chapters 91-101), Body_ID: ctrb30, Anthony 
Mundy, Jonathan Glass. Gray’s Anatomy Edition: The Anatomical Basis of 
Clinical Practice. 39th ed.  
98 
 
24.  Henry Gray. Anatomy of the Human Body,XI. Splanchnology3b. 3.The 
Urinary Bladder.. 1918.  
25.  Braddom R. Section III/Chapter 28/Management of Bladder 
Dysfunction,Physical Medicine and Rehabilitation. 4th ed. p. 601–18.  
26.  Fowler CJ, Griffiths D, de Groat WC. The neural control of micturition. 
Nat Rev Neurosci. 2008 Jun;9(6):453–66.  
27.  Fowler CJ, Griffiths DJ. A decade of functional brain imaging applied to 
bladder control. Neurourol Urodyn. 2010;29(1):49–55.  
28.  Sinha S, Sirigiri SR, Kanakamedala SK, Singh MK, Sharma RM. 
Duloxetine for treatment of male sphincteric incontinence following partial 
conus medullaris infarction after coronary bypass surgery. Cases J. 
2009;2:9094.  
29.  Bradbury EJ, McMahon SB. Spinal cord repair strategies: why do they 
work? Nat Rev Neurosci. 2006 Aug;7(8):644–53.  
30.  Ditunno JF, Little JW, Tessler A, Burns AS. Spinal shock revisited: a 
four-phase model. Spinal Cord. 2004 Jul;42(7):383–95.  
31.  George J, Tharion G, Richar J, Macaden AS, Thomas R, Bhattacharji S. 
The effectiveness of intravesical oxybutynin, propantheline, and capsaicin in 
the management of neuropathic bladder following spinal cord injury. 
ScientificWorldJournal. 2007;7:1683–90.  
32.  Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, et al. The 
standardisation of terminology of lower urinary tract function: report from 
the Standardisation Sub-committee of the International Continence Society. 
Neurourol Urodyn. 2002;21(2):167–78.  
33.  Ahmed HU, Shergill IS, Arya M, Shah PJR. Management of detrusor-
external sphincter dyssynergia. Nat Clin Pract Urol. 2006 Jul;3(7):368–80.  
34.  McKinley WO, Jackson AB, Cardenas DD, Vivo D, J M. Long-term 
medical complications after traumatic spinal cord injury: A regional model 
systems analysis. Arch Phys Med Rehabil. 1999 Nov;80(11):1402–10.  
35.  Braddom R. Section III/Chapter 28/Neuroanatomy and Physiology, 
Physical Medicine and Rehabilitation. 4th ed.  
36.  Stöhrer M, Blok B, Castro-Diaz D, Chartier-Kastler E, Del Popolo G, 
Kramer G, et al. EAU Guidelines on Neurogenic Lower Urinary Tract 
Dysfunction. Eur Urol. 2009 Jul;56(1):81–8.  
99 
 
37.  Patel HD, Livsey SA, Swann RA, Bukhari SS. Can urine dipstick testing 
for urinary tract infection at point of care reduce laboratory workload? J Clin 
Pathol. 2005 Sep;58(9):951–4.  
38.  Takeda M, Araki I, Kamiyama M, Takihana Y, Komuro M, Furuya Y. 
Diagnosis and treatment of voiding symptoms. Urology. 2003 Nov;62(5 
Suppl 2):11–9.  
39.  Darge K, Riedmiller H. Current status of vesicoureteral reflux diagnosis. 
World J Urol. 2004 Jun;22(2):88–95.  
40.  Kiesswetter H. EMG-patterns of pelvic floor muscles with surface 
electrodes. Urol Int. 1976;31(1-2):60–9.  
41.  West DA, Cummings JM, Longo WE, Virgo KS, Johnson FE, Parra RO. 
Role of chronic catheterization in the development of bladder cancer in 
patients with spinal cord injury. Urology. 1999 Feb;53(2):292–7.  
42.  Klausner AP, Steers WD. The Neurogenic Bladder: An Update with 
Management Strategies for Primary Care Physicians. Med Clin North Am. 
2011 Jan;95(1):111–20.  
43.  Schäfer W, Abrams P, Liao L, Mattiasson A, Pesce F, Spangberg A, et al. 
Good urodynamic practices: uroflowmetry, filling cystometry, and pressure-
flow studies. Neurourol Urodyn. 2002;21(3):261–74.  
44.  Donovan WH. Spinal Cord Injury--Past, Present, and Future. J Spinal 
Cord Med. 2007;30(2):85–100.  
45.  Cardenas DD, Kelly E, Mayo ME. Manual stimulation of reflex voiding 
after spinal cord injury. Arch Phys Med Rehabil. 1985 Jul;66(7):459–62.  
46.  Everaert K, Lumen N, Kerckhaert W, Willaert P, van Driel M. Urinary 
tract infections in spinal cord injury: prevention and treatment guidelines. 
Acta Clin Belg. 2009 Aug;64(4):335–40.  
47.  Kennelly MJ. A Comparative Review of Oxybutynin Chloride 
Formulations: Pharmacokinetics and Therapeutic Efficacy in Overactive 
Bladder. Rev Urol. 2010;12(1):12–9.  
48.  Kessler TM, Bachmann LM, Minder C, Lohrer D, Umbehr M, 
Schunemann HJ, et al. Adverse Event Assessment of Antimuscarinics for 
Treating Overactive Bladder: A Network Meta-Analytic Approach. PLoS 
ONE [Internet]. 2011 Feb 23 [cited 2013 Nov 26];6(2). Available from: 
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3044140/ 
100 
 
49.  Abrams P, Amarenco G, Bakke A, Buczyński A, Castro-Diaz D, Harrison 
S, et al. Tamsulosin: efficacy and safety in patients with neurogenic lower 
urinary tract dysfunction due to suprasacral spinal cord injury. J Urol. 2003 
Oct;170(4 Pt 1):1242–51.  
50.  Zullo MA, Plotti F, Calcagno M, Palaia I, Muzii L, Manci N, et al. 
Vaginal estrogen therapy and overactive bladder symptoms in 
postmenopausal patients after a tension-free vaginal tape procedure: a 
randomized clinical trial. Menopause N Y N. 2005 Aug;12(4):421–7.  
51.  Denys P, Schneider AE, Remy-Neris O, Ben-Smail D, Chartier-Kastler E, 
Ruffion A, et al. [Pharmacological treatment of neurogenic detrusor 
hyperactivity: intrathecal drugs]. Prog En Urol J Assoc Fr Urol Société Fr 
Urol. 2007 May;17(3):564–7.  
52.  Steele SS. Botulinum toxin A: First-line therapy for idiopathic detrusor 
overactivity. Can Urol Assoc J. 2011 Jun;5(3):207–9.  
53.  KUO H-C. Effectiveness Of Intravesical Resiniferatoxin For 
Anticholinergic Treatment Refractory Detrusor Overactivity Due To 
Nonspinal Cord Lesions. J Urol. 2003 Sep;170(3):835–9.  
54.  Gurung PMS, Attar KH, Abdul-Rahman A, Morris T, Hamid R, Shah 
PJR. Long-term outcomes of augmentation ileocystoplasty in patients with 
spinal cord injury: a minimum of 10 years of follow-up. BJU Int. 2012 
Apr;109(8):1236–42.  
55.  Hakenberg OW, Ebermayer J, Manseck A, Wirth MP. Application of the 
Mitrofanoff principle for intermittent self-catheterization in quadriplegic 
patients. Urology. 2001 Jul;58(1):38–42.  
56.  Ferreira RS, Levi d’Ancona CA, Dantas-Filho VP, Rodrigues Netto N Jr, 
Miyaoka R. [Percutaneous radiofrequency sacral rhizotomy in the treatment 
of neurogenic detrusor overactivity in spinal cord injured patients]. Actas 
Urol Esp. 2011 Jun;35(6):325–30.  
57.  Bezerra CC, Bruschini H, Cody JD. Traditional suburethral sling 
operations for urinary incontinence in women. Cochrane Database of 
Systematic Reviews [Internet]. John Wiley & Sons, Ltd; 1996 [cited 2013 
Nov 26]. Available from: 
http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD001754.pub2/abstra
ct 
101 
 
58.  Kerr LA. Bulking Agents in the Treatment of Stress Urinary Incontinence: 
History, Outcomes, Patient Populations, and Reimbursement Profile. Rev 
Urol. 2005;7(Suppl 1):S3–S11.  
59.  Kahlon B, Baverstock RJ, Carlson KV. Quality of life and patient 
satisfaction after artificial urinary sphincter. Can Urol Assoc J. 2011 
Aug;5(4):268–72.  
60.  Kim YH, Kattan MW, Boone TB. Bladder leak point pressure: the 
measure for sphincterotomy success in spinal cord injured patients with 
external detrusor-sphincter dyssynergia. J Urol. 1998 Feb;159(2):493–496; 
discussion 496–497.  
61.  Lettsomian Lectures ON THE TREATMENT OF STRICTURE OF THE 
URETHRA, ENLARGED PROSTATE, AND STONE IN THE BLADDER,. 
The Lancet. 1880 Apr;115(2955):591–3.  
62.  Guttmann L, Frankel H. The value of intermittent catheterisation in the 
early management of traumatic paraplegia and tetraplegia. Paraplegia. 1966 
Aug;4(2):63–84.  
63.  George M, Holmes L. Policy and Protocol for Intermittent Urethral 
Catheterisation of Adults and Children. [cited 2013 Nov 19]; Available from: 
http://www.brentpct.org/doxpixandgragix/NP16ISCpolicyedit.pdf 
64.  Lawrence WT, MacDonagh RP. Treatment of urethral stricture disease by 
internal urethrotomy followed by intermittent “low-friction” self-
catheterization: preliminary communication. J R Soc Med. 1988 
Mar;81(3):136–9.  
65.  Robertson GS, Everitt N, Lamprecht JR, Brett M, Flynn JT. Treatment of 
recurrent urethral strictures using clean intermittent self-catheterisation. Br J 
Urol. 1991 Jul;68(1):89–92.  
66.  Continence Care Forum [Internet]. 2009 [cited 2013 Dec 9]. Available 
from: 
http://www.rcn.org.uk/development/communities/rcn_forum_communities/co
ntinence_care 
67.  Szollar SM, Lee SM. Intravesical oxybutynin for spinal cord injury 
patients. Spinal Cord. 1996 May;34(5):284–7.  
68.  Mitrofanoff P. [Trans-appendicular continent cystostomy in the 
management of the neurogenic bladder]. Chir Pédiatrique. 1980;21(4):297–
305.  
102 
 
69.  Bladder Management for Adults with Spinal Cord Injury. J Spinal Cord 
Med. 2006;29(5):527–73.  
70.  Samson G, Cardenas DD. Neurogenic bladder in spinal cord injury. Phys 
Med Rehabil Clin N Am. 2007 May;18(2):255–274, vi.  
71.  Harrison SCW. Managing the urinary tract in spinal cord injury. Indian J 
Urol IJU J Urol Soc India. 2010;26(2):245–52.  
72.  Dmochowski RR, Ganabathi K, Leach GE. Non-operative management of 
the urinary tract in spinal cord injury. Neurourol Urodyn. 1995;14(1):47–55.  
73.  Pannek J, Sommerfeld HJ, Bötel U, Senge T. Combined intravesical and 
oral oxybutynin chloride in adult patients with spinal cord injury. Urology. 
2000 Mar;55(3):358–62.  
74.  MacDonald R, Fink HA, Huckabay C, Monga M, Wilt TJ. Botulinum 
toxin for treatment of urinary incontinence due to detrusor overactivity: a 
systematic review of effectiveness and adverse effects. Spinal Cord. 2007 
Aug;45(8):535–41.  
75.  Pannek J, Göcking K, Bersch U. Long-term effects of repeated 
intradetrusor botulinum neurotoxin A injections on detrusor function in 
patients with neurogenic bladder dysfunction. BJU Int. 2009 
Nov;104(9):1246–50.  
76.  Chartier-Kastler EJ, Mongiat-Artus P, Bitker MO, Chancellor MB, 
Richard F, Denys P. Long-term results of augmentation cystoplasty in spinal 
cord injury patients. Spinal Cord. 2000 Aug;38(8):490–4.  
77.  Hohenfellner M, Pannek J, Bötel U, Dahms S, Pfitzenmaier J, Fichtner J, 
et al. Sacral bladder denervation for treatment of detrusor hyperreflexia and 
autonomic dysreflexia. Urology. 2001 Jul;58(1):28–32.  
78.  Patki P, Hamid R, Shah PJR, Craggs M. Long-term efficacy of AMS 800 
artificial urinary sphincter in male patients with urodynamic stress 
incontinence due to spinal cord lesion. Spinal Cord. 2006 May;44(5):297–
300.  
79.  Stothers L, Chopra A, Raz S. Vaginal reconstructive surgery for female 
incontinence and anterior vaginal-wall prolapse. Urol Clin North Am. 1995 
Aug;22(3):641–55.  
80.  Monti PR, Lara RC, Dutra MA, de Carvalho JR. New techniques for 
construction of efferent conduits based on the Mitrofanoff principle. Urology. 
1997 Jan;49(1):112–5.  
103 
 
81.  Nicolle LE. Uncomplicated Urinary Tract Infection in Adults Including 
Uncomplicated Pyelonephritis. Urol Clin North Am. 2008 Feb;35(1):1–12.  
82.  Klevens RM, Edwards JR, Richards CL Jr, Horan TC, Gaynes RP, 
Pollock DA, et al. Estimating health care-associated infections and deaths in 
U.S. hospitals, 2002. Public Health Rep Wash DC 1974. 2007 
Apr;122(2):160–6.  
83.  Lusardi G, Lipp A, Shaw C. Antibiotic prophylaxis for short-term catheter 
bladder drainage in adults. Cochrane Database of Systematic Reviews 
[Internet]. John Wiley & Sons, Ltd; 1996 [cited 2013 Nov 18]. Available 
from: 
http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD005428.pub2/abstra
ct 
84.  Montgomerie JZ, Chan E, Gilmore DS, Canawati HN, Sapico FL. Low 
mortality among patients with spinal cord injury and bacteremia. Rev Infect 
Dis. 1991 Oct;13(5):867–71.  
85.  Bennett CJ, Young MN, Darrington H. Differences in urinary tract 
infections in male and female spinal cord injury patients on intermittent 
catheterization. Paraplegia. 1995;33(2):69–72.  
86.  Niël-Weise BS, van den Broek PJ, da Silva EM, Silva LA. Urinary 
catheter policies for long-term bladder drainage. Cochrane Database of 
Systematic Reviews [Internet]. John Wiley & Sons, Ltd; 1996 [cited 2013 
Nov 18]. Available from: 
http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD004201.pub3/abstra
ct 
87.  Maynard FM, Diokno AC. Urinary infection and complications during 
clean intermittent catheterization following spinal cord injury. J Urol. 1984 
Nov;132(5):943–6.  
88.  Moore KN, Fader M, Getliffe K. Long-term bladder management by 
intermittent catheterisation in adults and children. Cochrane Database Syst 
Rev. 2007;(4):CD006008.  
89.  Wyndaele J. Complications of intermittent catheterization: their 
prevention and treatment. Spinal Cord. 2002 Oct;40(10):536–41.  
90.  Gormley EA. Urologic Complications of the Neurogenic Bladder. Urol 
Clin North Am. 2010 Nov;37(4):601–7.  
104 
 
91.  Schwartz B, Bell DM, Hughes JM. Preventing the emergence of 
antimicrobial resistance: A call for action by clinicians, public health 
officials, and patients. JAMA. 1997 Sep 17;278(11):944–5.  
92.  Anderson RU. Prophylaxis of bacteriuria during intermittent 
catheterization of the acute neurogenic bladder. J Urol. 1980 
Mar;123(3):364–6.  
93.  Duffy L, Smith AD. Nitrofurantoin macrocrystals prevent bacteriuria in 
intermittent self-catheterization. Urology. 1982 Jul;20(1):47–9.  
94.  Mohler JL, Cowen DL, Flanigan RC. Suppression and treatment of 
urinary tract infection in patients with an intermittently catheterized 
neurogenic bladder. J Urol. 1987 Aug;138(2):336–40.  
95.  Johnson HW, Anderson JD, Chambers GK, Arnold WJ, Irwin BJ, Brinton 
JR. A short-term study of nitrofurantoin prophylaxis in children managed 
with clean intermittent catheterization. Pediatrics. 1994 May;93(5):752–5.  
96.  Schlager TA, Anderson S, Trudell J, Hendley JO. Nitrofurantoin 
prophylaxis for bacteriuria and urinary tract infection in children with 
neurogenic bladder on intermittent catheterization. J Pediatr. 1998 
Apr;132(4):704–8.  
97.  Zegers B, Uiterwaal C, Kimpen J, van Gool J, de Jong T, Winkler-Seinstra 
P, et al. Antibiotic prophylaxis for urinary tract infections in children with 
spina bifida on intermittent catheterization. J Urol. 2011 Dec;186(6):2365–
70.  
98.  Van den Berg MEL, Castellote JM, Mahillo-Fernandez I, de Pedro-Cuesta 
J. Incidence of Spinal Cord Injury Worldwide: A Systematic Review. 
Neuroepidemiology. 2010;34(3):184–92.  
99.  Karacan I, Koyuncu H, Pekel O, Sümbüloglu G, Kirnap M, Dursun H, et 
al. Traumatic spinal cord injuries in Turkey: a nation-wide epidemiological 
study. Spinal Cord. 2000 Nov;38(11):697–701.  
100.  McKinley W, Meade MA, Kirshblum S, Barnard B. Outcomes of early 
surgical management versus late or no surgical intervention after acute spinal 
cord injury. Arch Phys Med Rehabil. 2004 Nov;85(11):1818–25.  
101.  Dedeić-Ljubović A, Hukić M. Catheter-related urinary tract infection in 
patients suffering from spinal cord injuries. Bosn J Basic Med Sci Udruženje 
Basičnih Med Znan Assoc Basic Med Sci. 2009 Feb;9(1):2–9.  
105 
 
102.  Khanfar HS, Bindayna KM, Senok AC, Botta GA. Extended spectrum 
beta-lactamases (ESBL) in Escherichia coli and Klebsiella pneumoniae: 
trends in the hospital and community settings. J Infect Dev Ctries [Internet]. 
2009 May 1 [cited 2013 Dec 14];3(04). Available from: 
http://www.jidc.org/index.php/journal/article/view/19759493 
103.  Metri BC, Jyothi P, Peerapur BV. Detection of ESBL in E.coli and K. 
pneumoniae isolated from urinary tract infection. Indian J Nephrol. 
2012;22(5):401–2.  
104.  Taneja N, Rao P, Arora J, Dogra A. Occurrence of ESBL & Amp-C beta-
lactamases & susceptibility to newer antimicrobial agents in complicated 
UTI. Indian J Med Res. 2008 Jan;127(1):85–8.  
105.  Tankhiwale SS, Jalgaonkar SV, Ahamad S, Hassani U. Evaluation of 
extended spectrum beta lactamase in urinary isolates. Indian J Med Res. 2004 
Dec;120(6):553–6.  
106.  Stickler DJ, Chawla JC. An appraisal of antibiotic policies for urinary tract 
infections in patients with spinal cord injuries undergoing long-term 
intermittent catheterisation. Paraplegia. 1988 Aug;26(4):215–25.  
107.  Clarke SA, Samuel M, Boddy S-A. Are prophylactic antibiotics necessary 
with clean intermittent catheterization? A randomized controlled trial. J 
Pediatr Surg. 2005 Mar;40(3):568–71.  
108.  Gribble MJ, Puterman ML. Prophylaxis of urinary tract infection in 
persons with recent spinal cord injury: a prospective, randomized, double-
blind, placebo-controlled study of trimethoprim-sulfamethoxazole. Am J 
Med. 1993 Aug;95(2):141–52.  
. 
 
 
 
 
 
 
 
 
 
 
 
 
106 
 
ANNEXURE 
1. Institutional Review Board Acceptance letter. 
2. Patient Information Sheet and Consent Form 
3. Proforma of the study 
4. Data Sheet 
 
 
 
 
 
 
107 
 
 
 
 
 
108 
 
 
 
 
 
109 
 
  
INFORMED CONSENT 
 
Christian Medical College, Vellore 
Department of P.M.R 
 
”Role of Antibiotics during change over from continuous bladder drainage 
to intermittent clean catheterization in patients with Spinal cord injury” 
 
Information sheet 
 
You are being requested to participate in a study to see if a Antibiotic drug is 
needed to prevent urinary tract infection when spinal cord injury patients on 
long term catheter are started on Intermittent clean catheterization. We hope to 
include about 50 people from this hospital in this study. 
Why does the study done for? 
Spinal cord injury patients are usually on long term indwelling urinary 
catheters. Hence they are more prone for urinary tract infections. Studies have 
shown if these patients are taught intermittent clean cauterization (ICC), the 
chance of urinary infections are less and has more patient compliance. During 
starting of ICC there is chance of initial urinary retention & infection. But there 
are no much study regarding preventive antibiotic treatment during this period. 
Hence we wanted to do a clinical trial on this regard. 
 
If you take part what will you have to do? 
If you agree to participate in this study, you will be given either 5 days of 
treatment with urine culture sensitive Antibiotic or No medications. Neither you 
nor your doctor will have any choice in whether you will get Antibiotic or No 
medications as this will be decided by a computer program; this is like tossing a 
coin and you have an equal chance of getting either treatment.  
All other treatments that you are already on will be continued and your regular 
treatment will not be changed during this study. You will be monitored for 1 
week for any symptoms of urinary infection. Before starting the study you will 
be screened with routine blood & urine tests, Ultrasound test of abdomen and 
urine culture.  
 
If at any time you experience any problems, you will be expected to report this 
to the doctor.  
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Can you withdraw from this study after it starts? 
Your participation in this study is entirely voluntary and you are also free to 
decide to withdraw permission to participate in this study. If you do so, this will 
not affect your usual treatment at this hospital in any way. In addition, if you 
experience any serious side effects or your condition worsens, the study tablets 
will be stopped and you may be given additional treatment.  
 
What will happen if you develop any study related injury? 
There is no risk of any study related injury 
Will you have to pay for the study tablets?  
Antibiotic treatment will not be given free of cost since this is a routine 
protocol for ICC.  
Any other treatment that you usually take will continue but the usual 
arrangements that you have with the hospital will decide how much you pay for 
this. But if you are included in the control group(Non Antibiotic group) & if 
you develop Symptomatic urinary tract infection during the study period, the 
expense of the antibiotics will be provided by the researcher. 
What happens after the study is over? 
You may or may not benefit from the study drug that you are given.  
Will your personal details be kept confidential? 
The results of this study will be published in a medical journal but you will not 
be identified by name in any publication or presentation of results. However, 
your medical notes may be reviewed by people associated with the study, 
without your additional permission, should you decide to participate in this 
study.  
 
If you have any further questions, please ask Dr. Antony Sebastian D’cruz, 
Dr. Jacob George (tel: 0416 – 2282158 / 9159154181) or email: 
antonyanila@yahoo.co.in 
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CONSENT TO TAKE PART IN A CLINICAL TRIAL 
Study Title: “Role of Antibiotics during change over from continuous bladder 
drainage to intermittent clean catheterization in patients with Spinal cord injury” 
Study Number: 
Participant’s name:  
Date of Birth / Age (in years): 
 
I_____________________________________________________________ 
___________, son/daughter of ___________________________________ 
 
(Please tick boxes) 
Declare that I have read the information sheet provide to me regarding this 
study and have clarified any doubts that I had. [ ] 
 
I also understand that my participation in this study is entirely voluntary and 
that I am free to withdraw permission to continue to participate at any time 
without affecting my usual treatment or my legal rights [ ] 
 
I also understand that neither I, nor my doctors, will have any choice or 
knowledge of whether I will get Antibiotic treatment or No treatment [ ] 
 
I also understand that during the 1 week of the study, the Antibiotic tablet will 
NOT be provided free for 5 days [ ] 
 
I also understand if I am in the control group & if I develop symptomatic UTI 
during the study, I will be provided with antibiotic by the researcher [ ] 
 
I understand that the study staff and institutional ethics committee members 
will not need my permission to look at my health records even if I withdraw 
from the trial. I agree to this access [ ]  
 
I understand that my identity will not be revealed in any information released to 
third parties or published [ ]   
 
I voluntarily agree to take part in this study [ ] 
 
Name: 
Signature/ Thumb impression: 
Date:       Name of witness:  
        Signature/Thumb impression: 
Relation to participant: 
Date: 
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APPENDIX 
PROFORMA  
Case No.                                               Hospital No:                        Date: 
Name:                                                    Age :                                   Sex: 
Father’s /Husband’s Name 
Address                                                                                 
Phone No. 
Education                                                                   Income/Occupation 
Socio-economic status 
Email ID 
Clinical Details 
Mode of Injury 
 
 
Duration 
 
 
Surgery  
Ambulation  
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Bladder history 
Type 
 
CBD Foley/silicon 
SPC  
 
Diagnosis 
Type             Traumatic/Non Traumatic 
Vertebral level 
 
 
Motor level  
Sensory level 
 
 
Reflex level 
 
 
   
 Personal history: 
Smoking  
Alcohol  
Any drug allergy  
 
 Past History 
 Allergy 
 Bleeding disorders 
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Investigations: 
Hb 
 
 
TLC 
 
 
DLC 
 
 
 
ROUTINE  
URINE  
EXAMINATION 
 
URINE 
DIP 
STICK 
TEST 
 
USG-KUB 
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Case No.                    Name                                                
Hosp. No:    
General  examination: Pulse               BP                     Temperature 
 
ASSESSMENT 
 Before   ICC     1 Week after ICC  
 
  Fever 
  
  
  Urgency 
  
 
  Frequency 
  
 
  Dysuria, 
  
 
 Suprapubic tenderness, or 
 Cost vertebral angle pain or  
 Tenderness 
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     DATA SHEET 
slno hosp_no age gender group symputi cfuc dipstik gstain orgm 
1 442061F 26 1 2 2 1   3 
2 455382F 15 1 1 2 1   1 
3 474593F 34 1 1 2 1   1 
4 614364F 28 1 2 1 2 1 1 1 
5 464648F 17 1 1 2 1 1 1 2 
6 191594F 27 1 2 2 1   3 
7 407753F 38 1 2 2 1 1 2 1 
8 494460F 55 1 1 2 1 1 1 1 
9 608191F 49 1 1 2 1   1 
10 850466A 51 1 2 2 1   2 
11 476099F 20 2 1 2 1   2 
12 476664F 30 1 2 2 1 1 1 1 
13 606929F 55 1 2 2 1 1 1 3 
14 623741F 36 1 1 2 1 1 1 1 
15 420296F 26 1 1 2 1 1 1 2 
16 474666F 46 1 2 2 1   3 
17 438049F 22 1 2 2 1 1  2 
18 654817F 27 1 2 2 1   2 
19 620895F 14 1 1 2 1   2 
20 649193F 40 1 1 2 2 1 1 1 
21 636186F 13 1 1 2 1 1 1 3 
22 657829F 18 1 2 2 1   1 
23 777159D 26 1 2 2 1 1 1 2 
24 686418F 53 1 1 2 1  1 3 
25 693502F 30 1 1 2 1   1 
26 651519C 50 1 1 1 2 1 2  
27 686235F 16 2 2 2 1 1 1 2 
28 487389F 26 2 2 2 1 2 2 1 
29 698988F 38 2 1 2 1   2 
30 687576F 40 1 2 2 2 1 2 2 
31 702537F 19 1 1 2 1 1 1 1 
32 693061F 33 2 2 2 1 1 1 3 
Key to Data sheet 
Category  
Gender  Study group 
Symptomatic 
UTI(symputi
) 
Colony 
forming units 
count(cfuc) 
Dipstick 
test 
Gram 
stain 
1 
Male  Antibiotic  Present  ≥10
5
 CFU/ml Positive Positive 
2 
Female  Non antibiotic  Absent  
≥103 and <105 
CFU/ml Negative  Negative  
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                                             DATA SHEET 
Slno. Microbe 1 Microbe 2 Microbe 3 Level P/T CAUSE DOI SX AB 
1 Pseudo Kleb ESBL Ecoli ESBL T7 1 RTA 2 1  
2 E.coli ESBL   T10  1 FALL 1 1 NFN 
3 E.coli   T10  1 FALL 1 1 NFN 
4 Proteus   T4  1 RTA 1 1  
5 Ecoli ESBL Citro  L2 1 WOB 4 1 NFN 
6 Pseudo Entero Ecoli L1 1 FALL 4 1  
7 E.coli   T12 1 FALL 4 1  
8 E.coli ESBL   T4 1 RTA 1 1 NFN 
9 E.coli ESBL   T11 1 FALL 2 1 NFN 
10 Entero Ecoli ESBL  L1  1 FALL 5 1  
11 Pseudo E.coli  T11  1 FALL 1 1 NFN+LEVO 
12 Kleb ESBL   T12  1 WOB 1 1  
13 Pseudo Providencia MRSA T4   1 FALL 1 2  
14 Entero   L2  1 FALL 1 1 COTRI 
15 Kleb ESBL E.coli  T8  1 TB 3 2 NFN+COTRI 
16 Citro Entero KLEB T10   1 FALL 1 1  
17 Entero Ecoli ESBL  T11  1 RTA 2 1  
18 Entero Kleb Carb RES  C8  2 RTA 1 1  
19 Entero Kleb ESBL  T5  1 FALL 4 1 NFN+AMC 
20 E.coli ESBL   T6  1 FALL 1 1 NFN 
21 Pseudo E.coli ESBL Ecoli 2 ESBL T4  1 FALL 1 1 NFN+LEVO 
22 E.coli ESBL   T10  1 FALL 1 1  
23 Kleb ESBL E.coli ESBL  T9  1 FALL 4 1  
24 Serratia E.coli ESBL Proteus L4  1 FALL 3 2 AMI 
25 E.coli ESBL   T12  1 RTA 1 1 AMI 
26    L3  1 IVDP 1 1 NFN 
27 E.coli ESBL Kleb  T11  1 FALL 2 1  
28 NF GNB    T9  1 TM 3 2  
29 Entero E.coli  T11 1 FALL 1 1 NFN 
30 Ecoli Pseudo  T12  1 FALL 1 1  
31 E.coli ESBL   T9   1 RTA 1 1 NFN 
32 Kleb ESBL Ecoli ESBL Pseudo T6  1 TM 3 2  
Key to Data sheet 
Level=level of injury  
P/T  1= Paraplegic,2= Tetraplegic 
DOI=Duration of injury <3M=1, <6M=2, <1 YEAR=3, <5 YEAR=4,  > 5YEAR=5 
SX  SURGERY =1,CONSERVATIVE =2 
AB=Antibiotic 
NFN=Nitrofurantoin,  COTRI=Co-Trimoxazole , LEVO=Levofloxacin 
AMC=Amox-clav,        AMI=Amikacin 
 
